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ABSTRACT
This research focuses on the phenotypic and genotypic charac­
teristics of a temperature sensitive mutant of herpes simplex virus 
type 1, HSV-1 (tsZAl). This virus was previously reported to carry 
two different mutations, which caused it to be temperature sensitive 
for viral replication and transport of glycoproteins to the infected cell 
surface. However, altered glycoprotein transport to the cell surface 
was not observed in this study. In addition, cells transformed with 
unique long gene 28 (UL28), but not glycoprotein B (gB), comple­
mented tsZAl at the nonpermissive temperature indicating that a single 
mutation could restore the wild type phenotype to the mutant virus.
A UL28-null vims (gCA7B) was not capable of complementing 
the tsTAl mutation, indicating that the mutation was within the UL28 
gene and there was no other mutation elsewhere. Surprisingly to 1203, 
containing a mutation in the UL28 gene region, was able to rescue the 
wildtype phenotype. This suggests intragenic (allelic) complemen­
tation.
Marker rescue experiments were used to determine the region 
of the genome which contained a mutation. A panel of overlapping 
cloned DNA fragments from the wild type vims were co-transfected 
with infectious viral DNA into Vero cells. A single area of 1333 base 
pairs within the UL28 gene region rescued the wildtype phenotype.
Transfer of this single region into an otherwise wild type viral 
genome resulted in a virus that was phenotypically identical to tsZAl.
This confirmed that a single mutation was responsible for the 
observed phenotype of tsTLAl.
Sequence analysis of this region revealed a single mutation, C to 
T, that substituted 53 tryptophan for 531 Arginine. Computer 
analyses were used to predict the effects of this mutation.
DNA from tsTAl infected cells is present in long concatemers 
rather than being cleaved to genomic length. In addition, electron 
microscopic analysis revealed that DNA was not being packaged into 
the nucleocapsids.
It can be concluded that HSV-1 (tsTAl) does not have a defect in 
glycoprotein transport and contains only a single mutation in the 
UL28 gene. This mutation affects the ability of the virus to effec­
tively cleave and package DNA.
x
CHAPTER 1 
INTRODUCTION
Background
The study of herpesviruses is important in human and animal 
medicine and many different methods have been used to examine these 
viruses. Utilizing temperature sensitive (ts) mutant viruses, allows 
scientists to assess the function of particular genes in viral replication. 
A temperature sensitive virus replicates poorly or not at all at elevated 
temperatures due to a mutation in an essential gene.
Almost a decade ago a report was published describing an inter­
esting temperature sensitive mutant virus of herpes simplex type 1 
(HSV-1). This mutant was originally denoted as icr tsl%, but is now 
known as tsZAl (Pancake etal., 1983). Two important characteristics 
of this virus were revealed.
First, the vims displayed a defect in the transport of glyco­
proteins to the infected cell surface. Glycoproteins are important for 
herpesvirus entry and egress from cells. Glycoproteins are also 
involved in the fusion of neighboring cells. Our laboratory is con­
cerned with the events of cell to cell fusion. This fusion results in 
spread of the vims without the vims entering the extracellular 
environment. Vims tsTAl presented a unique opportunity to study the 
process by which glycoproteins were being translocated within a cell 
and might possibly provide an opportunity to study glycoprotein 
involvement in cell to cell fusion.
1
2Second, the virus was found to have two separate mutations. At 
least one of these mutations was thought to be localized in the unique 
long gene 28 (UL28) of the HSV-1 genome. The second mutation was 
localized to the region of the genome containing unique long genes 1 
through 5 (UL1 to UL5). The repair of either mutated region resulted 
in a virus that replicated as the wild type parent strain HSV-1 (KOS).
It is highly unusual for repair of one mutation in a ts virus to fully 
restore the wild type phenotype.
Statement of the Research Problem 
In the time since the first research was published in 1983, there 
has been confusion regarding tsZAl. Part of the confusion stemmed 
from the repair of each mutation restoring the wild type phenotype. It 
is much more common in double mutants such as tsZAl, for each 
mutation to restore only part of the wild type phenotype. Laboratories 
studying various genes of herpesviruses have attempted to explain the 
nature of the mutation in tsZAl but have had limited success.
Additional controversy came from recent publications that indicated 
that the UL28 gene was not involved in glycoprotein transport.
Objectives of the Research Project
This research project was undertaken to examine the role of 
tsZM  in glycoprotein transport and to clarify the nature of the tsZAl 
mutations. The objectives of this research were to characterize 
temperature sensitive mutant virus HSV-1 (taZ47) and to assess the role 
of the UL28 in HSV-1 viral infections. The specific aims of the 
projects were:
1. To clarify the effect of the mutation(s) in HSV-1 (tsTAl) 
on glycoprotein transport to the cell surface.
2. To localize the regions of mutation(s) that were reported 
to be present in HSV-1 (tsTAl).
3. To identify the genes involved, and to identify the 
mutation(s) by DNA sequencing.
4. To characterize the phenotype and physical attributes of 
HSV-1 (taZ47) mutant virus.
It is important to note that the results presented here in this 
document strongly suggests that tsZAl does not affect the transport of 
glycoproteins to the cell surface and that the virus contains only a 
single mutation lying in the unique long gene 28 (UL28). The specific 
research projects are divided into four chapters entitled: Analysis of 
Glycoproteins of tsTAl, Analysis of tsTAl by Genetic Complemen­
tation, Mapping of the Mutation in tsTAl, and Examination of Cleavage 
and Packaging and Electron Microscopic Evidence of the Mutation in 
tsTAl.
A knowledge of basic herpesvirus biology will aid in under­
standing the experimental procedures and results that yielded these 
conclusions. The remainder of this chapter is devoted to a brief review 
of herpesvirus biology and research that is relevant to the experiments 
presented here.
Herpesvirus History
Diseases in man that can be attributed to herpesviruses have been 
described for over 2500 years. Physicians in early civilizations
4recognized the pattern of spread of this disease and gave it the name 
"herpes" which is the Greek word Hepnsct, "to creep". The origin and 
uses of the word herpes was reviewed (Beswick, 1962). One of the 
first description of herpes simplex was given by Daniel Turner in a 
1714 treatise on skin ailments (Beswick, 1962). In 1921, Lipschiitz 
proposed that two different versions of the same agent were causing 
herpes genitalis and labialis (Hamilton, 1980), but it took over 40 years 
before the actual causative agent, a vims, was isolated and initially 
characterized (reviewed by Roizman, 1982). Although many other 
strains have been described, herpes simplex viruses were the first 
identified and characterized, and herpes simplex vims type 1 (HSV-1) 
remains the prototype vims of the family.
Herpesviruses have been isolated from nearly all animal species 
studied. Seven unique herpesviruses have also been isolated from 
humans, each playing a role in morbidity and mortality among diverse 
human populations. All herpesviruses have large genomes composed of 
double stranded deoxyribonucleic acid (DNA) ranging from 120,000 to 
230,000 base pairs in length. The genome codes for some 70 to 100 
proteins including enzymes for nucleic acid metabolism, DNA synthesis 
and replication (Roizman, 1991). An exhaustive review of known 
herpesviruses among mammals, birds, amphibians, reptiles and fish, 
was recently published (Roizman and Baines, 1991).
H erpesvirus Biology
A nomenclature which classifies herpesviruses was defined by the 
International Committee on the Taxonomy of Viruses (Roizman et al.,
1981). Herpesviruses may be subdivided into three major subfamilies: 
alphaherpesvirinae, betaherpesvirinae, and gammaherpesvirinae. This 
classification is based on physical properties but not necessarily 
evolutionary relationship. The alphaherpesvirinae subfamily (or alpha 
herpesviruses) are grouped on the basis of wide host range and a short 
reproductive cycle of 12 to 24 hours. This subfamily contains the 
genera herpes simplex types 1 (HSV-1) and 2 (HSV-2), human 
herpesvirus 3 (HHV-3; varicella-zoster), suid herpesvirus 1 (pseudo­
rabies virus of swine; PRY), cercopithecine herpesviruses 1 and 2 (B 
and SA8 viruses of monkeys), equine herpesvirus-1 (EHV-1; equine 
abortion virus), bovine herpesviruses 1 and 2 (BHV-1; infectious 
bovine rhinotracheitis virus and BHV-2; bovine mammillitis virus) and 
the newly characterized ictalurid herpesvirus 1 (IHV-1; channel catfish 
virus).
Members of the betaherpesvirinae subfamily are less well defined 
but all appear to have a reproductive cycle of 7 to 14 days and a 
restricted host range; usually infecting cells of a secretory nature 
(Roizman and Baines, 1991). Cells infected with betaherpesvirinae 
characteristically become enlarged (cytomegaly). Common members 
of this genera are human herpesvirus 5 (HHV-5; cytomegalovirus), 
aotine herpesvirus 1 and murine cytomegalovirus.
Gammaherpesvirinae also appear to demonstrate a restricted host 
range, replicating and becoming latent almost exclusively in cells of 
lymphoblastoid lineage. However, they are capable of causing lysis in 
epithelial cells or fibroblasts. Gamma herpesviruses are associated with 
tumor formation and oncogenicity as observed by the relationship
between Epstein-Barr virus and Burkitt's lymphoma (Kieff and 
Liebowitz, 1991). Common genera include human herpesvirus 4 
(HHV-4; Epstein-Barr virus), aotine herpesvirus 2 (herpesvirus aotus 
type 2), cercopithecine herpesvirus 12 (baboon herpesvirus), pongine 
herpes-virus 1 (chimpanzee herpesvirus), saimirine herpesvirus 
(herpesvirus saimiri), gallid herpesvirus 2 (Marek's disease), and 
meleagrid herpesvirus 1 (turkey herpesvirus).
Complete DNA sequence information for the genome is available 
for HHV-1 (McGeoch et al., 1988; GenBank accession # X14112), 
HHV-3 (Davison and Scott, 1986; GenBank accession numbers X04370, 
X02132, X00208, M16612, M14891), HHV-4 (GenBank accession 
numbers V01555, V01554, V01509), HHV-5 (Chee et a l, 1990a; 
GenBank accession # X17403), IHV-1 (Davison, 1992; GenBank 
accession # M75136) and EHV-1 (Telford et al., 1992). Partial DNA 
sequence information is available from other species for many strains 
of herpesviruses. Genetic and sequence analysis, and comparison 
among many members of this family, have confirmed similarities and 
conserved regions among genomes suggesting that a common ancestral 
vims may have existed (McGeoch, 1989).
Analysis of the evolutionary relationship between vimses reveals 
a slightly different grouping or classification than one based on 
physical properties. Marek's disease of chickens is classified as a 
gamma herpesvirus by physical properties, but genetically is grouped 
with alpha herpesviruses. HHV-6 shares biological functions with 
gamma herpesviruses, but is genetically more similar to cytomegalo­
virus and the other betaherpesvirinae (Roizman and Baines, 1991).
7Such variations are to be expected as a more thorough understanding of 
genetic organization and evolution of this virus family emerges.
Although differences between herpesviruses are common there 
are four significant biological features that can be used to group them:
1. All herpesvirus genomes code for a large number of proteins 
and enzymes required for viral protein and nucleic acid 
metabolism.
2. Synthesis of viral DNA and assembly of the capsids occurs in 
the nucleus, and egress of mature particles occurs through 
budding and envelopment at the nuclear membrane.
3. Production of infectious progeny results in irreversible lysis 
of the infected cell.
4. All herpesviruses are capable of remaining latent in the host 
cells in the absence of production of viral particles. During 
latency the genome of the viruses resides as a closed circle 
and only a few viral genes are transcribed.
The physical parameters of the vims particle have been well 
characterized. A labeled cross-sectional drawing of a herpes simplex 
virion is presented in Figure 1. Each virion is composed of a double 
stranded DNA core, capsid, tegument and envelope (Roizman, 1991). 
The core contains a single double stranded DNA molecule that is in the 
form of a torus (Furlong et al., 1972). The capsid is approximately 
100 nm in diameter, composed of 162 capsomeres and is icosadelta- 
hedral in shape (Roizman and Sears, 1991). The capsomers are 
subdivided into 12 pentamers, one at each vertex, and 150 hexamers, 
composing the rest of the capsid. The tegument is composed of a
Envelope
Glycoproteins
Figure 1. Diagram of the Herpesvirus Virion.
CO
proteinaceous material that lies between the capsid and the envelope 
(Roizman and Furlong, 1974). Some proteins that may be important 
for the shut off of host genes or induction of viral genes may be 
carried in this layer (Batterson and Roizman, 1983; Campbell et al., 
1984). The envelope of herpesvirus particles is a lipid bilayer and 
appears to be derived from of the nuclear membrane. The envelope 
contains large numbers of protruding spikes that are composed of 
glycoproteins (Stannard et al., 1987). Overall, the virions range in 
diameter from 120 nm to almost 300 nm.
Genome Organization
The genomes of HSV-1 and HSV-2 are very similar in organ­
ization and have been reviewed extensively by Roizman (1979). Figure 
2 shows the prototypic organization of the herpes simplex viral 
genome. The genome is composed of two linked segments; the unique 
long (Ul) and the unique short (Us) components. Each unique region 
is flanked by inverted repeat regions. It is known that the U l and Us 
components can invert relative to each other during replication yielding 
populations of virus genomes that are present in four equimolar 
amounts (Hayward et al., 1975). Functional organization of the 
genome has been characterized by the use of temperature sensitive 
mutants and complementation mapping and grouping (Weller et al., 
1983a; 1983b). Marker rescue and transfer techniques have also been 
used to localize ts mutations in specific gene regions. Site-specific 
insertion and deletion mapping utilizing thymidine kinase as a selection 
marker have been used to determine whether genes are essential for
'L u <
ab
CZ>
b’ a'; a c’
{~ r > -
c a
Figure 2. Herpes Simplex Virus Type 1 Genome Arrangement. 
The unique long (UL) and unique short (Us ) portions of the genome are
shown as a straight line, while boxes are used to indicate terminal repeat 
regions. Small letters a, b, b’, c, and c’ are used to indicate orientation of 
specific repeated DNA elements.
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vims growth in culture (Post et al., 1981). To date some 58 open 
reading frames (ORF) or infected cell proteins (ICP) have been desig­
nated in the U l component and 12 in the Us component (reviewed by 
McGeoch, 1987, 1989).
Stages of Virus Infection
Herpesvirus infections can be broken down into seven stages: 
attachment, penetration, host shut off, regulated gene transcription, 
DNA replication, latency and assembly and egress. The stages are 
diagrammed in Figure 3.
Attachment. Specific and non-specific mechanisms by which 
herpes virions can attach to the cell surface have been proposed. Non- 
specific attachment involves interaction of a heparan sulfate proteo­
glycan with domains of the virion envelope (WuDunn and Spear,
1989). Recently it was shown that highly sulfated proteoglycans with a 
minimum of 10 monosaccharide units appear necessary for interaction 
with the vims (Lycke et al., 1991). Inhibition experiments revealed 
that either or both glycoprotein C (gC) and glycoprotein B (gB) are 
involved in the attachment process (Spear et al., 1992). There are in 
vivo tropisms for tissue and species that are not exhibited in culture 
suggesting that other glycoproteins may be involved in this process.
Penetration. Once the vims attaches to the cell membrane a 
process of fusion of the viral envelope to the cell plasma membrane 
begins. The vims capsid enters the cell following fusion of the vims 
envelope with the plasma membrane of the host cell. Little, if any 
virus enters the cell through endocytosis or phagocytosis, and neither
Fusion /  
Penetration
Attachment
/
Release of DNA
Replication
O Transcriptiona-mRNA 
p-mRNA 
y-mRNA
Endoplasmi
eticulum
Cleavage and 
Packaging
0 (X-protemsP-proteins
y-proteinsAssembly
Glycoprotein
Maturation
Figure 3. HSV-1 Virus Life Cycle. Specific stages of the virus life cycle are detailed 
in a flow chart maimer. Each event is explained in a section of the text.
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of these modes of entry results in a productive infection (Campadelli- 
Fiume et al., 1982; Campadelli-Fiume et al., 1988). The fusion process 
results in the capsid and surrounding tegument being released into the 
cytoplasm. Glycoproteins B, D and H are essential for vims entry, but 
not attachment to the cell. A gH-null vims can attach to the cell 
membrane but does not penetrate (Desai et al., 1988). Monoclonal 
antibodies to gH also inhibit vims penetration (Fuller et al., 1988). 
Similarly, temperature sensitive mutants in glycoprotein B attach but 
do not penetrate (Manservigi et al., 1977). A gD-null vims allows 
attachment and endocytosis, but not fusion (Johnson and Ligas, 1988) 
and a specific domain near gD amino acid 25Leu precludes penetration 
(Campadelli-Fiume et al., 1988).
The exact nature of transport of capsids to the nucleus is unclear 
but it is speculated to involve the cellular cytoskeleton (Kristensson et 
al., 1986). The capsid "docks" with the nuclear membrane at a nuclear 
pore and DNA is released into the nucleus from the capsid presumably 
by a viral encoded function (Tognon et al., 1981). This hypothesis is 
supported by mutant vims tsB l which fails to release DNA into the 
nucleus. This results in the build up of full capsids near the nuclear 
pores (Batterson et al., 1983).
Host Shut Off. Infection of cells by herpesviruses leads to a 
shut off of host macromolecular synthesis very early in the course of 
the infection (reviewed by Fenwick, 1984). Proteins necessary for 
primary host shut off may be carried inside the virion, probably in the 
tegument (Fenwick and Walker, 1978). Temperature sensitive vimses 
mutated in the virion host shut off function (VHS) were unable to
14
degrade host cell mRNA, or immediate early viral mRNA (Read and 
Frenkel, 1983; Kwong et al., 1988). This indicates that VHS may play 
a role in regulation of viral mRNA as well. Absence of VHS does not 
stop infection, but alters and lengthens the time course of infection.
Regulated Gene Transcription. Viral replication and 
transcription occur in a cascade-like fashion. Viral proteins can be 
divided into three major classes which are coordinately regulated 
(Honess and Roizman, 1974).
Alpha gene (immediate early gene) transcription is thought to be 
activated by alpha trans-inducing factor (a-TIF) (Pellett et al., 1985) 
also known as VP16 (Heine et al., 1974) or Vmw 65 (Campbell et al., 
1984; Dalrymple et al., 1985). Alpha-TIF is a viral protein that is 
carried in the infecting particle (Post et al., 1981; Campbell et al., 
1984; Pellett et al., 1986). Alpha genes are transcribed by host cell 
RNA polymerase II following release of DNA into the nucleus 
(Costanzo et al., 1977). These mRNA are predominant at 2 to 4 hours 
post infection but may be found at later times at lower levels (Honess 
and Roizman, 1974). There are five known alpha genes; ICPO, 4, 22, 
27 and 47. All except ICP47 are known to be involved in regulation 
(Mackem and Roizman, 1982; Hubenthal et al., 1987; Stevens et al., 
1987). Alpha gene products are essential for transcription and 
synthesis of later genes and function through feedback inhibition; down 
regulating their own production. (Dixon and Schaffer, 1980; DeLuca 
and Schaffer, 1985; O'Hare and Hayward, 1985).
ICPO appears to be a trans-activator and to work synergistically 
with ICP4. Mutant viruses deleted in ICPO replicate more slowly than
15
wild type controls (Sacks and Schaffer, 1987). ICP4 is the major 
trans-activator of viral transcription and is essential for virus growth as 
demonstrated by ICP4-null viruses and numerous temperature sensitive 
mutants. ICP4 autoregulates its own shut off and possibly that of ICPO 
(DeLuca and Schaffer, 1988; Roizman and Sears, 1991). ICP22 is 
either essential or dispensable depending on the cell line utilized, 
however, ICP27 appears to be essential (Sears et al., 1985). Both 
proteins have been shown to affect expression of y-genes (Sears et al., 
1985; McCarthy et al., 1989).
Alpha gene proteins are required for transcription of p-genes. 
Beta class genes can be separated into two groups, early beta (pi) and 
late beta (P2). While pi proteins are produced first, both groups reach
peak rates of synthesis near 5 to 7 hours post infection (Honess and 
Roizman, 1974). Major pi-genes include the ribonucleotide reductase, 
and major DNA-binding protein, while the P2-genes include the
thymidine kinase and DNA polymerase (reviewed by Knipe, 1989). In 
most cases, p-genes are involved in nucleic acid metabolism and their 
expression is enhanced in the absence of DNA synthesis (Roizman,
1991).
Gamma genes can also be divided into two groups. Expression 
of these late genes is generally stimulated by viral DNA synthesis. 
Gamma-1 genes are grouped because they are not dependent on viral 
DNA synthesis for expression and include gB and gD. Gamma-2 genes 
are dependent on viral DNA synthesis for expression and include gC 
(Roizman and Sears, 1991). Most y-genes code for structural proteins 
or are involved in maturation of progeny virus particles.
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DNA Replication. HSV-1 DNA replication is the focus of 
intense study and has been thoroughly reviewed by Roizman (1979), 
Knipe et al. (1981), McGeoch (1987) and Challberg and Kelly (1989). 
DNA from infectious particles that enter the nucleus is thought to 
quickly circularize, possibly through direct ligation of compatible ends 
(Davison and Wilkie, 1983; Poffenberger and Roizman, 1985). The 
genome carried in the capsid has staggered "sticky" ends that are part 
of the terminal repeat "a" region (Figure 2). It is predicted that circu­
larization of the genome is dependent on this region (Poffenberger and 
Roizman, 1985). Only a small portion of the viral DNA that enters a 
cell will undergo replication. The method of replication in early stages 
of infection is unclear but during later stages of replication it is 
believed that HSV-1 replicates in a rolling circle fashion (Jacob et al., 
1979). Newly synthesized DNA does not have significant termini and 
is suspected to be either circular or form head to tail concatemers 
(Jacob et al., 1979). Newly amplified DNA is found in a rapidly 
sedimentable form, indicating large concatemers (Jacob et al., 1979). 
The ability of HSV-1 to generate four isomeric genomes has been 
reviewed (Roizman, 1979). Isomerization of the genome occurs in 
vivo, but is not essential for replication in culture (Poffenberger and 
Roizman, 1985).
Replication may progress in either direction, and originate from 
any origin of replication. HSV-1 contains three origins of replication 
(ori). Two are found in the reiterated "c" portion (Figure 2) of the Us 
component (Mocarski and Roizman, 1982; Deb and Doelberg, 1988), in 
a transcribed open reading frame (Hubenthal et al., 1987). One origin
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(oriL) is found in the UL between the promoters for ICP8 and the DNA 
polymerase (Spaete and Frenkel, 1985; Weller et al., 1985). The oriL 
consists of an A-T rich, 144 bp perfect palindrome, which is unstable 
when cloned into E. coli (Weller et al., 1985). The oriL and at least 
one of the oris can be deleted without affecting virus replication 
(Roizman and Sears, 1991).
Viral DNA replication appears to take place in nuclear compart­
ments where all required enzymes and synthetic precursors are 
sequestered (reviewed by Knipe, 1989) but there remains some dispute 
over this interpretation. The requirements for DNA synthesis were 
studied using cells transfected with an origin of replication and other 
cloned HSV-1 DNA fragments (Challberg, 1986; Challberg and Kelly, 
1989). Seven genes in the U l  component are necessary for replication 
in cell culture: UL5 - part of the helicase/primase; UL8 - part of the 
helicase/primase; UL9 - origin binding protein; UL29 - single strand 
binding protein; UL30 - DNA polymerase; UL42 - double strand DNA 
binding protein; and UL52 - part of the helicase/primase (Roizman and 
Sears, 1991).
The DNA polymerase (UL30) was first described by Keir and 
Gold, (1963) and further study of the DNA polymerase revealed a 
single polypeptide (136 KDa), which exhibits a 3' to 5' exonuclease 
proofreading activity (Knopf, 1979). The polymerase demonstrates 
unusual sensitivity to such compounds as phosphonoacetate and 
nucleotide analogs (acycloguanosine) as reviewed by Coen et al., (1984) 
and Honess et al., (1984). This information forms the basis for recent
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developments of antiviral therapeutics such as acyclovir and 
gancyclovir.
The exact role of the DNA binding protein has not been eluc­
idated, but it is essential for replication (Weller et al., 1983b) and 
appears to be able to dissociate double stranded DNA in vitro (Powell 
et al., 1981).
HSV specified alkaline DNase activity was first reported by Keir 
and Gold, (1963). This enzyme displays a 5' and 3' exonuclease and 
endonuclease activity and is essential for replication in infected cells in 
culture, but not essential in the in vitro studies described above 
(Roizman and Sears, 1991). The nature of this enzyme remains 
obscure, however, it is speculated that this enzyme plays a role in host 
DNA degradation thereby providing synthetic raw material for viral 
DNA synthesis (McGeoch, 1987).
Several other enzymes involved in nucleic acid metabolism and 
recycling, which appear important in vivo, are apparently not essential 
for growth in vitro; these enzymes include thymidine kinase, ribo­
nucleotide reductase, uracil-DNA glycosylase and dUTPase (Roizman 
and Sears, 1991).
Latency. There is an alternate pathway following virus entry 
into cells. Viral DNA can, under certain conditions, enter a state of 
latency and not pass into the replication stage of infection. All of the 
herpesviruses studied to date can enter this latent state. During this 
state no infectious virions are produced, and the virus genome exists 
quiescently in the cell expressing a small number of genes whose 
identity and function remains unclear. Epstein-Barr virus is the
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prototype virus studied for its latency properties (Kieff and Liebowitz,
1991). In herpes simplex viruses the most common site of latency is 
the sensory neuron (Roizman, 1991). In an attempt to describe the 
stage of latency animal models using mice, rabbits and guinea pigs, as 
well as models using cultured cells have been explored (Roizman and 
Sears, 1987; Nsiah and Rapp, 1991). In cultured neurons the latent 
state is maintained in the presence of nerve growth factor, and the virus 
reactivates when the growth factor is withdrawn from culture (Wilcox 
and Johnson, 1987). There is some doubt regarding the relevancy 
latency models in cultured cells because latency is induced via drugs or 
nonstandard temperature regimes that do not duplicate in vivo 
conditions (Roizman and Sears, 1991).
Replication in epithelial tissue places the virus in proximity to 
sensory neurons. Virus particles are thought to enter the nerve ending 
and be translocated through the process of retrograde axonal transport. 
This process is thought to involve the microtubules in the neuron cell 
body (Kristensson et al., 1986). Electron microscopy revealed that 
unenveloped capsids are the particles that are transported (Lycke et al.,
1984). A cell enters is said to enter latency when no replicating virus 
can be detected in that cell.
The last stage of latency is reactivation. Stimuli such as hor­
monal changes, tissue damage and even physical or emotional stress can 
result in viral replication in the latent neuron. Activation is accom­
panied by viral replication, and progeny virus being axonally trans­
ported to peripheral tissue. It is generally understood that active
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replication leads irreversibly to cell death, however the fate of the 
previously latent neuron remains unclear (Roizman and Sears, 1991).
The events of latency are still poorly understood at the molecular 
level. The genome may exist in a relatively high copy number per 
latently infected cell; up to 100 copies per cell (Cabrera et ah, 1980; 
Rock and Fraser, 1983; Puga et al., 1984; Roizman and Sears, 1987).
It has been proposed that the vims genome in latently infected neurons 
is present either as a circular episomal form or as integrated concat- 
emeric forms (Rock and Fraser, 1983; Roizman and Sears, 1987). The 
episomal hypothesis for HSV-1 is most attractive for two reasons.
First, other DNA viruses which establish latency, such as papilloma 
vims and EBV, follow this pattern and second, in active infection viral 
DNA circularizes following entry into the nucleus. Neither process 
appears to require gene transcription (Poffenberger and Roizman,
1985).
The latency associated transcript (LAT) is suggested to be 
involved in maintenance of latency (Stevens et al., 1987), because it is 
present in high numbers in the nuclei of neurons that are latently 
infected with HSV-1. LAT represents a population of spliced mRNAs 
(Wagner et al., 1988a) that do not appear to be polyadenylated 
(Wagner et al., 1988b). The mRNA of LAT is complementary to the 
3' terminus of ICPO and is thought to prevent expression of ICPO 
protein. However, these researchers have also shown that a vims 
deleted for LAT is able to establish latency (Javier et al., 1988). Even 
though LAT undergoes active transcription during latency, it does not 
appear to be necessary for the establishment of latency. In addition
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these authors showed that herpesvirus deleted for LAT could reactivate 
as well (Javier et al., 1988). Therefore, there does not currently 
appear to be any virus-specified gene transcript necessary for 
establishment of latency. Possible host cell factors that may play a role 
in latency remain elusive.
A model for the establishment of latency proposes that oc-TIF 
becomes separated from the capsid upon entry into the neuron due to 
retrograde axonal transport, and without oc-TIF, the oc-genes cannot be 
transcribed (Roizman and Sears, 1987). However, it was recently 
reported that the presence or absence of oc-TIF was not sufficient to 
cause or prevent establishment of latency (Sears et al., 1991).
Assembly, DNA Cleavage, and Egress of Particles. 
Following primary infection or reactivation from the latent state, DNA 
replication and assembly of the capsid take place in the nucleus of a 
herpesvirus infected cell. Maturation of vims particles can be divided 
into three major stages: First, assembly of empty capsids within the 
nucleus. Second, insertion of genomic length DNA into the formed 
capsids. Third, budding of filled capsids from the nuclear membrane 
when the particles acquire the lipid membrane known as the envelope.
Early studies on the nature of HSV-1 infection revealed that viral 
protein components necessary for capsid production are synthesized at 
the rough endoplasmic reticulum and then transported to the nucleus 
where assembly occurs (Morgan et al., 1954; Reissig and Melnick, 
1955). The process by which capsids are assembled is unclear, but 
assembly and packaging of the capsids may take place on some sort of 
nuclear matrix (Ben-Zeev etal., 1983; Quinlan and Knipe, 1983). The
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herpesvirus capsid is composed of at least seven virus specified 
proteins: VP5, VP19C, VP21, VP22a, VP23, VP24 and VP26.
Deletion mutants in VP5 and VP23 revealed that at least these two are 
essential for capsid formation and DNA cleavage (Desai et al., 1993). 
VP26 is present only in filled capsids (type B) and enveloped capsids 
(type C), and is highly and variably phosphorylated (Preston et al., 
1992). VP26 is observed to self assemble into defined structures in 
vitro which may indicate a role as a possible scaffold protein for 
double stranded DNA (Preston et al., 1992).
There are thought to be approximately 900 molecules of VP5 per 
capsid in equine herpesvirus type 1. The approximate ratio of virion 
proteins is VP5 (9): VP19C (7): VP21 (1): VP22a (9): VP23 (4) : 
VP24 (1): VP26 (14) (Newcomb et al., 1989). VP5 is present in 
approximately six copies per hexameric capsomere (Heine et al., 1974; 
Vemon et al., 1981) and may be part of the pentameric capsomeres as 
well (Schrag et al., 1989). VP19C is apparently linked to VP5 through 
a disulfide bond (Zweig et al., 1979). VP19C binds DNA and may be 
involved in anchoring viral DNA to the capsid (Braun et al., 1984a). 
Type B particles contain two additional proteins, VP21 and VP22a, 
while Type C particles contain VP21 and VP22 but not VP22a (Gibson 
and Roizman, 1972; Gibson and Roizman 1974). VP22 and VP22a are 
grouped with the ICP35 class of proteins (Braun et al., 1984b) and 
VP22 is thought to be a cleavage product of VP22a (Gibson and 
Roizman, 1972). Other studies indicate that VP22a and VP22 may not 
be related (Sherman and Bachenheimer, 1987; Rixon et al., 1988)
More recently, Davison et al. (1992) identified two genes, UL26 and
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UL26.5 which are 3' co-terminal but begin from different initiation 
sites. UL26 codes for VP24 and VP21 which are separated by a 
proteolytic cleavage site. VP22a is coded by UL26.5 initiated from 
within, and 3' co-terminal to the UL26 coding region (Davison et al.,
1992).
Following or concurrent with assembly, concatemeric strings of 
HSV-1 DNA are cleaved to genomic length and packaged into the 
capsids. Packaging of DNA into the empty capsid is highly correlated 
with cleavage of DNA to unit length (Ladin et al., 1980; Stow et al., 
1983; Deiss et al., 1986; Deiss and Frenkel, 1986; Sherman and Bach- 
enheimer, 1987). The "a" region (Figure 2), found in the terminal 
repeats contains an essential packaging signal and at least one copy of 
this region is necessary for packaging of viral DNA (Stow et al., 1983). 
The "a" sequences range in size from 250 to 500 bp, depending on the 
number of reiterated repeat regions they contain (Deiss et al., 1986). 
The "a" signal sequence serves as the site for cleavage of unit length 
genomes. Cleavage results in duplication of the "a" signal (Deiss and 
Frenkel, 1986). The actual "a" region can be subdivided into several 
elements including Uc and Ub regions (Deiss et al., 1986). In deletion 
experiments, Deiss et al. (1986) showed that deletion of the Uc region 
resulted in no packaging at all, while deletion of the Ub region yielded 
some packaging that was aberrant and included portions of the helper 
virus DNA.
The mechanism of cleavage and packaging remains to be eluc­
idated but two models were proposed (Deiss et al., 1986). The first is a 
directional packaging model that describes a packaging complex that
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encounters viral DNA, then scans until it encounters a Uc region. At 
the Uc region cleavage occurs and packaging begins. The complex 
continues to scan in the Ul to Us direction while packaging DNA until 
a Ub region is encountered. At the Ub region a second cleavage occurs 
and a unit-length genome is packaged.
The second model proposed begins in the same fashion with a 
packaging complex encountering a Uc region and initiating cleavage. 
The scanning and packaging continues until the next Uc-Ub region is 
encountered. When two such Uc-Ub regions of DNA are juxtaposed, a 
gene conversion mechanism is utilized in duplication of the "a" 
sequence in both regions. Following duplication of the "a" region, the 
final cleavage occurs yielding a packaged unit copy genome. Only 
after successful packaging of DNA into the capsid does egress from the 
nucleus occur.
The mature virion acquires an envelope by budding from the 
nuclear membrane (Darlington and Moss, 1968). However, there is 
speculation of a more complicated process of repeated envelopment and 
de-envelopment as the capsid migrates or is transported to the extra­
cellular milieu. Following viral protein synthesis at the ribosomes and 
glycosylation in the Golgi apparatus (Campadelli-Fiume and Serafmi- 
Cessi, 1984), the glycoproteins and possibly anchor or tegument 
proteins are transported in a retrograde fashion back to the nucleus and 
embedded in the nuclear membrane. It is known that the envelope of a 
particle budding from the nuclear membrane contain only high 
mannose forms of glycoproteins (Kousoulas et al., 1983). Full
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glycosylation takes place as the particles traverse the Golgi. The exact 
nature of this migration remains unknown.
A discovery was made regarding particle formation during HSV- 
1 infections. When virions were purified through gradient centri­
fugation two distinct bands were present; a lower, heavy band 
(designated as H particles) and a lighter diffuse band (designated as L 
particles). Analysis of these L particles revealed that they contained 
envelope and tegument proteins but lacked any capsid proteins or DNA 
(Szilagyi and Cunningham, 1991). The tegument portion of these 
particles has a defined shape even in the absence of envelope or a 
capsid, indicating that tegument may have a defined structure 
(McLauchlan and Rixon, 1992). Further examination revealed that 
these particles contain at least two phosphoproteins that are not present 
in H particles (Szilagyi and Cunningham, 1991). The presence of novel 
proteins suggests that these particles are a specific product of the 
infection and not a breakdown product due to handling of the samples. 
Vims to 1203 (Matz et al., 1983) which does not form infectious virions 
at the nonpermissive temperature, was examined and found to produce 
L particles at levels similar to wild type vimses, suggesting L particles 
are made by a separate pathway from normal particles (Rixon et al.,
1992). Interestingly, L particles were found to contain significant 
amounts of ICP4, the cc-gene trans-activator, and surprisingly, H 
particles (infectious virions) were found to contain very little ICP4 
(McLauchlan and Rixon, 1992). L particles were found to be 
biologically competent to deliver membrane and tegument associated
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proteins to the cell during infection and thus participate in the 
infectious process (McLauchlan et al., 1992).
Characterization of the UL28 Gene Region
The presence of the UL28 gene was initially proposed by the dis­
covery of a new complementation group between gB and the major 
DNA binding protein (Dixon et al., 1983). Transcriptional analyses of 
the region revealed three mRNA transcripts of 10, 5.6 and 3.3 Kb, 
which are 3' co-terminal. They represent gB, UL28 + gB and gB + 
UL28 + DNA binding protein, respectively. A 4.2 Kb message 
representing DNA binding protein alone was also discovered (Holland 
et al., 1984).
The nucleotide sequence of an open reading frame within this 
region was determined. The open reading frame of UL28 codes for a 
putative 780 amino acid protein with a predicted molecular weight of 
83,845 (Pellett et al., 1986; Hammerschmidt et al., 1988). A peptide 
was synthesized corresponding to a hydrophilic region near the 
carboxy terminus of the predicted protein. Sera raised against this 
peptide reacted with a 95.5 kDa protein designated ICP18.5 (Pellett et 
al., 1986). A 78 kDa ICP18.5 homolog was identified in pseudorabies 
(PRV) infected cells and purified using a polyclonal antibody generated 
against a lambda Cro-ICP18.5 (PRV) fusion protein (Pederson and 
Enquist, 1991). There was great difficulty in expressing this protein in 
E. coli and it was considered lethal to the bacteria (N. Pederson, 
personal communications). Expression resulted from a spontaneous 
mutation in the bacterial strain that allowed for expression of the
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plasmid containing PRV-ICP18.5. The expressed protein was purified 
and used to generate polyclonal anti-serum (Pederson and Enquist, 
1991).
Analysis of PRV-ICP18.5 production in infected cells showed 
that, like other early gamma genes such as gB, levels of the protein 
were not significantly reduced in the absence of viral DNA synthesis 
(Pederson and Enquist, 1991). The protein could be detected as early 
as 2 hours post-infection, but not earlier (Pederson and Enquist, 1991). 
Localization studies using immunofluorescence and subcellular 
fractionation demonstrated the PRV-ICP18.5 was localized to discrete 
sites throughout all of the nucleus, except the nucleolus, as early as 1 to 
2 hours post-infection, then spread gradually throughout the entire 
nucleus. Recently, an 87 kDa protein was identified from HSV-1 
infected cells using a polyclonal anti-serum specific for HSV-1 ICP18.5 
(Tengelsen et al., 1993). The UL28 gene is highly conserved among 
alpha herpesviruses as reviewed by Pederson and Enquist (1991). 
Briefly, conservation of this gene and neighboring gB exists among 
HSV-1 strains (Knopf, 1987; McGeoch et al., 1988) and between HSV- 
1 and HSV-2 (Bzik et al., 1986), human cytomegalovims (Chee et al., 
1990b), Epstein-Barr vims (Pellett et al., 1985; Pellett et al., 1986; 
Gompels et al., 1988), herpes siamiri (Gompels et al., 1988; Albrecht 
and Fleckenstein, 1990), pseudorabies vims, (Pederson and Enquist, 
1989), bovine herpesviruses (Hammerschmidt et al., 1988; Whitbeck et 
al., 1988; Griffin, 1991), equine herpesviruses (Riggio et al., 1989; 
Whalley et al., 1989), and Marek's disease (Ross et al., 1989).
The conserved nature of UL28 and gB is the reason a large 
amount of sequence information is available. Conservation of a gene 
region among different species of herpesviruses indicates that UL28 
may have an important function in vims replication. The following 
chapters will describe experiments and results from studies using HSV- 
1 (wZ47) and discuss the role of UL28 in herpesvirus replication.
CHAPTER 2 
ANALYSIS OF GLYCOPROTEINS OF tsZ41
Introduction
Glycoproteins are involved in aspects of viral infectivity 
including attachment, penetration and viral egress. Viral glycoproteins 
also serve as the major targets for the host immune system. HSV-1 
specifies at least eleven glycoproteins denoted as glycoprotein B (gB) 
through glycoprotein L (gL). At least four glycoproteins, gB, gD, gK 
and gH are thought to be involved in cell to cell fusion. Cell fusion is 
thought to be a mechanism of virus spread to proximal cells by which 
the virus evades the immune response. As described in the intro­
duction, HSV-1 (tsTAl) was initially characterized as having a defect in 
glycoprotein transport to the infected cell surface (Pancake et al.,
1983). Virus tsZ.41 was isolated after mutagenesis of HSV-1 (KOS) 
with 2-aminopurine. The virus was selected for the ability to survive in 
the presence of antibody against HSV-1 glycoprotein B (gB) and 
guinea pig complement (Machtiger et a l, 1980). The vims was 
described as immune cytolysis resistant. Surface labeling of cells 
infected with tsTAl at the nonpermissive temperature (39°C) revealed a 
greatly reduced pattern of expression of gB, gC, and gD. At the same 
time no reduction in total production of glycoproteins was observed 
(Pancake etal., 1983).
It was of interest to study a mutant vims that was defective in 
transport of many glycoproteins to the cell surface. It was hypothe­
sized that if a single gene was responsible for transport of multiple
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glycoproteins, a coordinated complex might be involved, and possibly 
lead towards a better understanding of vims mediated cell fusion.
This chapter focuses on the role of the temperature sensitive 
mutation of tsTAl in glycoprotein production, maturation and transport 
to the cell surface and describes experiments and data from metabolic 
and surface labeling of vims glycoproteins. The evidence presented 
indicates that in contrast to the previously published report, no 
significant defect in glycoprotein expression was observed for mutant 
vims tsTAl.
Materials and Methods
Cells and Viruses. African green monkey kidney cells (Vero) 
and human larynx epidermoid carcinoma cells (HEp-2) (ATCC, 
Rockville, MD) were grown and maintained in Dulbecco's Modified 
Eagles Medium (DMEM; Sigma, St. Louis, MO) supplemented with 
10% heat-inactivated fetal bovine semm (FBS; Gibco-BRL, Grand 
Island, NY). Vero cells were used for generation of vims stocks and 
for metabolic labeling experiments. HEp-2 cells were used for the 
surface labeling experiments due to the resilient nature of these 
fibroblast cells. HSV-1 (KOS), the designated wild type vims, and 
HSV-1 (tsTAl), the mutant vims, were provided by Dr. P. Schaffer 
(Dana-Farber Cancer Inst., Boston, MA).
Virus Stocks. Vero cells were infected at a multiplicity of 
infection (MOI) of 0.01 plaque forming units per cell (PFU/cell). 
Culture medium was removed from cells and medium without semm 
was added to the flasks. Vims was added to the medium and allowed
to adsorb for 1 hour at room temperature (25°C) with gentle rocking. 
Medium containing 5% FBS was replaced in the flask and the infection 
was allowed to proceed until full cytopathic effect (CPE) was observed 
(48 to 72 hours post-infection). Virus stocks were made by collecting 
infected cells from culture flasks. Cells were sedimented by centri­
fugation and the supernatant was discarded and an equal volume of 
medium and 10% skim milk was added to the mixture. Skim milk is 
used as a cryoprotectant to help preserve the infectivity of the viral 
stocks during storage. Virus stocks were frozen and thawed three times 
then sonicated to break cell membranes and release the virus. Stock 
were titered as described below then stored frozen at -70°C.
Metabolic Labeling of Viral Glycoproteins. Vero cells in 25 
cm2 flasks were infected with vims at a MOI of 10 PFU/cell. Vims 
was allowed to adsorb for 1 hour at room temperature with gentle 
rocking. The medium and remaining vims were removed and fresh 
medium was replaced. Cells were allowed to incubate at their 
respective temperatures (34°C or 39°C) for 4 hours. At 4 hours post­
infection, 5 microcuries (ju.Ci)/ml of 3H-mannose was added to the 
medium. Mannose is only incorporated into glycoproteins and it was 
added at 4 hours post-infection to insure shut off of host cell protein 
synthesis and incorporation into viral glycoproteins only. The infection 
was allowed to continue until 20 hours post-infection when medium 
and free label were removed and the cells washed twice with medium 
without semm. Cells were then lysed in situ using 50 mM Tris, 2% 
sodium dodecyl sulfate (SDS), 5% 2-mercaptoethanol (2-ME) and
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0.005% bromophenol blue. Lysates were collected from flasks and 
frozen at -20°C until later electrophoresis.
Surface Labeling. Surface proteins were iodinated using 
125Iodine (NEN-Dupont, Wilmington, DE) and Iodo-Beads™ (Pierce 
Chemical, Rockford, IL) following the protocol provided by the 
manufacturer and as described previously (Markwell, 1982). Briefly, 
HEp-2 cells were infected with a MOI of 10 PFU/cell. At 10 hours 
post-infection cells were scraped from the flask into the medium, 
washed twice with phosphate-buffered saline (PBS) and collected by 
centrifugation. Iodo-Beads™ were rinsed with PBS and air dried. Five 
minutes before use the beads were mixed with 100 pi of PBS and 0.25- 
0.5 millicuries (mCi) of sodium 125Iodide. Cells from a 25 cm2 flask 
were resuspended in 50 pi PBS and transferred to the iodination tubes. 
The vessels were mixed gently and the reaction allowed to continue for 
10 minutes at room temperature. Following incubation, the cell 
suspension was sedimented in 5 ml of fresh medium and cells were 
resuspended and washed three times in PBS. Labeled cells were 
resuspended in 150 pi of lysis buffer and frozen at -20°C. The lysis 
buffer contained: 1% nonidet P-40 (NP-40) and 0.5% sodium deoxy- 
cholate (DOC) dissolved in 10 mM Tris pH 8.0 and 1 mM EDTA (TE),
Antibodies and Radioimmunoprecipitation. Mouse mono­
clonal antibodies (mAB) specific for gB (HSB1) and gC (HSC1) were 
developed in our laboratory using standard procedures and were 
described previously (Baghian et al., 1993). The mAB to gH (52-S) 
was obtained from ATCC (ATCC: HB 8182).
Aliquots from radiolabeled lysates (100 jal) from surface labeling 
experiments were mixed with specific mAB. These mixtures were 
incubated with continuous rocking, for 1 to 2 hours at 4°C to form 
antigen-antibody complexes. Protein A-sepharose (5 mg) in 200 pi 
lysis buffer was then added to the mixture and rocking incubation 
continued for 1 to 2 hours at 4°C. The Fc portion of the antibody binds 
to the protein A linked to the sepharose bead. Antigen-antibody com­
plexes captured on sepharose beads were sedimented by centrifugation 
and washed four times by sedimentation and resuspension in lysis 
buffer to remove any free antibody and protein which did not bind to 
the antibody and to protein A-sepharose. The complexes were 
resuspended in electrophoresis loading buffer (2% SDS, 5% 2-ME, 50 
mM Tris (pH 8) and 0.005% bromophenol blue) to dissociate proteins. 
Samples were stored frozen at -20°C until electrophoresis.
Gel Electrophoresis. SDS -polyacrylamide gels (acrylamide: 
bis-acrylamide; 29:1) were used for protein separation; the stacking gel 
was 5% and the resolving gel was 10%. All protein samples were 
thawed and boiled for 5 minutes prior to loading in the gel. Molecular 
weight marker proteins (Pharmacia-LKB, Piscataway, NJ) were run 
alongside samples to determine approximate molecular masses. Gels 
were electrophoresed for 16 to 18 hours at constant voltage of 10 to 15 
volts/gel. Gels were fixed and stained to visualize bands. The fixative 
was composed of 45% water, 45% methanol, 10% acetic acid and 
0.25% Coomassie brilliant blue was added as a staining agent. Gels 
containing 3H-mannose labeled samples were impregnated with 
En3Hance™ (NEN®-Dupont Boston, MA) to augment the signal from
the radiolabled proteins. Gels were dried on a vacuum gel drying 
apparatus and used to exposed X-Omat AR™ film (Eastman Kodak, 
Rochester, NY) for autoradiography.
Results
Metabolic Labeling of Viral Glycoproteins. The bands visible 
in Figure 4 represent only virus specified glycoproteins since 3H- 
mannose was exclusively incorporated into glycoproteins after host cell 
metabolism was shut off by the virus. There were distinct differences 
in the pattern of polypeptides between viruses grown at 34°C and 39°C 
(Figure 4). Significant polypeptides are present at approximately 43 
and 60 kilodaltons (KDa) in both viruses propagated at 39°C that are 
absent or reduced when the same viruses are propagated at 34°C. 
However, no apparent differences were observed between tsTAl and 
KOS when propagated at 39°C. Virus tsTAl appears to produce similar 
levels of glycoprotein compared to KOS.
Surface Labeling. Radiolabeled lysates of infected cells were 
immunoprecipitated as described using mAB to gB, gC or gH. Figure 
5 contains photographs of the resulting autoradiographs. There were no 
apparent differences for gB and gC surface expression by tsTAl at 34°C 
or 39°C (Figure 5 lanes 1-8). Expression of gH at 39°C was elevated 
for KOS and decreased for tsTAl compared with levels at 34°C (Figure 
5 lanes 9-12). Autoradiographs were not subjected to analysis with a 
densitometer, therefore small differences in intensity of the polypeptide 
bands may have escaped visual detection. The glycoproteins migrated
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Figure 4. Metabolically Labeled Glycoproteins. Vero cells were 
infected with either KOS or tsTAl at a MOI of 10 PFU/cell. At 6 hours 
post-infection (h.p.i.) 3H-mannose (5(iCi/ml; NEN®-Dupont) was 
added to the cultures. Cells were lysed at 20 h.p.i. and lysates were 
electrophoresed as described in the Materials and Methods. Lanes 1 
and 8 are molecular weight markers. Lanes 2 and 3 are ts7Al\ lanes 4 
and 5 are KOS; lanes 6 and 7 are mock infected cells incubated at 34°C 
(lanes 2 ,4  and 6) or 39°C (lanes 3,5 and 7).
tsTAl I KOS I Mock
M 34 39 34 39 34 39 
mm « * •  mm ■ « p
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Figure 5. Surface Labeled Glycoproteins. HEp-2 cells infected with KOS (lanes 1-2,5-6,9-10) or 
tsTAl (lanes 3-4,7-8,11-12) were incubated at 34°C (lanes 1,3,5,7,9,11) or 39°C (lanes 2,4,6,8,10,12), 
then cell surface proteins were labeled with 125-I, and immunoprecipitated using monoclonal antibodies to 
gB (lanes 1-4), gC (lanes 5-8) or gH (lanes 9-12).
w
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at molecular weights indicating mature, fully glycosylated proteins. No 
significant immature polypeptides were seen.
Discussion
The experiments described in this chapter were designed to 
identify the effects of the mutation(s) in tsZ47 on glycoprotein 
priduction, maturation and expression. The total metabolic labeling of 
glycoproteins with 3H-mannose revealed no significant differences 
between the wild type and the temperature sensitive mutant. This is 
consistent with previously published reports. The difference in 
polypeptide patterns between 34°C and 39°C was examined. 
Comparison with previously published results indicates that these 
probably represent precursors to mature glycoproteins, most probably 
gD and gB (Kousoulas et al., 1983). Accumulation of glycoprotein 
precursors may be a result of altered viral protein synthesis at 39°C.
The polypeptides may be reduced or absent from the 34°C temperature 
point due to proper maturation. During proper maturation mannose 
residues are removed and replaced with more complex oligosac­
charides.
In the surface labeling experiments normal levels of gB and gC 
were observed to be present on the surface of tsZ47 infected cells 
incubated at 39°C, however, it can be inferred that small differences in 
gH expression may exist. These results are in contrast to previous 
surface expression experiments (Pancake et al., 1983) which showed 
almost total absence of gB, gC and gD at the cell surface.
There is support however, to indicate that UL28 does not play a 
role in glycoprotein transport. The protein product of UL28 is infected 
cell polypeptide 18.5 (ICP18.5). The ICP18.5 homolog in pseudorabies 
vims was examined and found not to interact with any glycoproteins 
(Pederson and Enquist, 1991; Mettenleiter et al., 1993). Recently, it 
was reported that a UL28-null vims (gCA7B) expressed gD on the cell 
surface in a normal pattern (Tengelsen et al., 1993). These results are 
consistent and support evidence presented here that UL28 is not 
involved in glycoprotein transport or expression on the cell surface.
Alternatively, it is possible that virion particles egressing from 
the infected cells can somehow transport additional glycoproteins to the 
cell surface. Retention of virion particles may cause the 2 to 3-fold 
defect observed in glycoprotein transport.
Results presented here indicate that there are no significant 
defects in glycoprotein production, maturation or expression on the cell 
surface. The next area that was explored dealt with ascertaining the 
location of the mutation in tsTAl. In the next chapter genetic comple­
mentation experiments used to identify the genes involved in the 
mutation will be described.
CHAPTER 3
ANALYSIS OF fcZ47 BY GENETIC COMPLEMENTATION
Introduction
The tsTAl mutant of HSV-1 was initially characterized as having a 
3 log drop in titer when propagated at 39°C and it displayed a defect in 
glycoprotein transport to the cell surface. Marker rescue results initially 
indicated two sites of mutation in tsTAl (Pancake et al., 1983). To localize 
the two mutations complementation testing was used.
Viral complementation testing revealed previously that tsTAl was 
able to complement all vimses tested including tsl 12 which contains a 
mutation in gB (Schaffer et al., 1978). Successful complementation 
included several viruses whose mutations mapped to the left end of the 
genome (UL1-UL5) where one of the proposed mutations existed. Com­
plementation failed to occur only with two HSV-2 viruses, tslOl and ts?>9 
(Dixon et al., 1983). Since both of these HSV-2 ts mutant vimses have 
mutations in the region containing unique long gene UL28, it was suggested 
that the mutation lay in UL28.
In experiments presented in this chapter, the location of the mutation 
was assessed using two approaches. Cellular complementation was initally 
used to localize the specific gene which may contain a mutation. Cells can 
be transformed with a herpesvirus gene, and upon infection with HSV-1 the 
gene is expressed. Transformed cell lines can be used to complement 
missing or mutated viral proteins (Coen, 1990). The cellular complemen­
tation described here utilized Vero cells that were transformed for specific 
genes (gB and UL28) ofHSV-1.
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In a second set of experiments, the ability of tsZAl to complement 
other vimses was tested using another te mutant in UL28 (tel203) and a 
UL28-null vims (gCA7B). Through the use of both these experiments 
evidence is presented to show that teZ47 contains a single mutation, in the 
UL28 gene.
Materials and Methods
Cells and Viruses. Vero cells and culture medium have been 
described previously in Chapter 2. Baby hamster kidney cells (BHK) were 
obtained from American type culture collection (ATCC, Rockville, MD). 
Cell lines Cl and Al were a gift from Dr. F. Homa (Upjohn Company, 
Kalamazoo, MI) and have been described previously (Tengelsen et al., 
1993). Briefly, these cells were transformed with DNA fragments 
containing the UL28 gene (Cl) and UL28 + gB genes (Al). Cell line D6 
was provided by Dr. S. Person (University of Pittsburgh, PA) and has been 
transformed with the gB gene (Cai et al., 1987). BHK cells were used to 
produce viral stocks of tel203. Cell lines A l, C l, and D6 were utilized for 
the cellular complementation experiments.
HSV-1 (KOS), and teZ47 were described in Chapter 2. HSV-1 
(tel203) was provided by Dr. V. Preston (MRC Virology Unit, Institute of 
Virology, Glascow, Scotland). The UL28-null vims, gCA7B, was a gift 
from Dr. F. Homa. Vims gCA7B was constmcted using a plasmid that 
contained a tmncated UL28 gene. The plasmid was transfected into Vero 
cells and through recombinant events within the cell, vimses were produced 
which contained the deleted UL28 gene within their genome. The vims 
was selected and grown on Cl cells transformed for the UL28 gene. The 
plasmid used to make this vims contained a UL28 gene that had been
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inactivated by removing a 537 bp Xhol to Xhol fragment from the 3' end of 
the gene. The UL28 gene product (ICP18.5) was truncated after amino acid 
526. A 268 bp fragment from the gC promoter region was inserted into the 
gap to restore a portion of the gB promoter that had been deleted in the 
process. This effectively placed gB under the control of the gC promoter 
(Tengelsen et al., 1993).
Virus Stocks. Stocks were prepared as described in Chapter 2.
Virus Infectivity Assay. Vims stocks from experiments were 
titered and compared to the titer of similarly generated KOS and tsTAl 
stocks. Infectivities were measured using a standard plaque assay. Briefly, 
Vero cells (90% confluent) were infected using 10-fold dilutions of vims 
from 10_1 to 10-8- Vims was allowed to adsorb to cells for 1 hour at room 
temperature with gentle rocking. Medium and remaining vims were 
removed and medium containing 5% FBS and 0.5% molecular biology 
grade agarose was added. Duplicate plates were placed at either 34°C or 
39°C. Plaques were counted under a microscope and verified by fixing 
cells (90% methanol, 5% formalin, 5% acetic acid) and staining with Gram 
crystal violet. Comparison were made between titers at 34°C and 39°C. A 
method of comparison was utilized by Pancake et al., (1983) in which the 
ratio of infectivity between the two temperatures was compared against a 
similar ratio of infectivity in HSV-1 (KOS). The formula used was:
(PFU/ml at 39°C / PFU/ml at 34°C) • 1000.
Cellular and Viral Complementation Studies. Cell lines A l, C l,
D6 or Vero were infected at a MOI of 5 PFU/cell with either KOS or tsTLM. 
Vimses were allowed to adsorb for 1 hour then removed and replaced with 
fresh medium. Duplicate cultures were incubated at either 34°C or 39°C 
for 24 hours. Following incubation, vims stocks were collected and titered
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at 34°C to determine the number of infectious progeny virus that were 
produced.
Vero cells were infected at a MOI of 5 PFU/cell with either tsTAl, 
te l203, gCA7B or paired combinations of these viruses. Viruses were 
allowed to adsorb for 1 hour then inoculating fluid was removed and 
replaced with fresh medium. Infected cells were incubated at 39°C for 24 
hours. Following incubation, virus stocks were collected and titered to 
determine the number of infectious progeny virus that were produced. 
Complementation indices are calculated based on the formula: [titer of 
A+B] / [(titer of A)+ (titer of B)] that has been described previously 
(Ramig, 1990), where A and B represent two different temperature sensitive 
vimses. Complementation is said to occur if this index is greater than 2.0.
Results
Cellular Complementation Experiments. C l, A l, D6 and Vero 
cells were infected with tsTAl or KOS as described. Cells were incubated 
at permissive (34°C) or nonpermissive (39°C) temperatures. Vims stocks 
were prepared after 24 hours and titered on Vero cells at 34°C. At the 
nonpermissive temperature tsTAl replicated efficiently in Cl cells and Al 
cells, compared with the KOS strain. This indicated that a protein produced 
by the transformed cells was able to complement the missing viral function 
(Table 1). However, tsTAl displayed the characteristic temperature sen­
sitive drop in titer in both D6 and Vero cells (Table 1). Wild type vims 
strain KOS replicated equally well in cell lines C l, D6 and Vero at both 
temperatures. Both vimses were able to replicate more effectively in Cl 
than in Al cells. This has been observed previously (F. Homa, personal 
communications).
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TABLE 1
Cellular Complementation of KOS and £sZ47 with Cell Lines 
Transformed for HSV-1 Genes
PFU/mla  Complementation
Virus Cells** 34°C_______ 39°C Efficiency b
Al 1.0 x lO 7 1.7 xlO 6 170.0
Cl 1.8 xlO 7 1.8 xlO 7 1000.0
D6 5.0 x lO 6 1.0 x lO 2 0.02
Vero 1.0 x 107 7.0 x 102 0.7
KOS c
Al 2.0 x 108 1.8 x 107 90.0
Cl 2.0 x 108 4.0 x 108 2000.0
D6 2.0 x 108 5.0 x 108 2500.0
Vero 3.0 x 107 7.6 x 107 2533.3
a Titer of vims stocks on Vero cells at 34°C in PFU/ml.
^ Complementation efficiency is reported as described previously (titer of
vims grown at 39°C) /  (titer of vims grown at 34°C) • 1000 (Pancake et 
a l, 1983).
c Vimses (MOI=5) were used to infect cell lines at either 34°C or 39°C. 
Viral stocks were made at 24 hours post-infection.
d  Cell line Al (gB and UL28), Cl (UL28), D6 (gB) and Vero (control).
Viral Complementation Experiments. Viral complementation 
experiments were performed with vimses gCA7B, toZ47 and tol203. Titers 
of each vims alone were used as controls and to determine the complemen­
tation indices. Complementation indices were calculated as described and 
are reported in Table 2 for each pair or vimses tested. The average of three 
experiments is reported. The UL28 deletion vims, gCA7B, failed to com­
plement either toZ47 or to 1203. However, toZ47 and to 1203 complemented 
each other (Table 2).
Discussion
A cell line transformed for UL28 was capable of complementing 
toZ47 and could restore wild type behavior, however, a cell line 
transformed for gB was not. Viral complementation assays support this 
evidence. Vims gCA7B which has a large deletion in UL28 was unable to 
complement to 1203, a known to mutant in UL28, and it also did not 
complement toZ47.
These complementation results indicates a single mutation in the 
UL28 region is likely to be responsible for the observed phenotype. Two 
regions for mutations were initially reported in toZ47. If either mutation 
region was repaired, full wild type phenotype was restored. Mixed 
infections with gCA7B and toZ47 served to test this conjecture. The only 
difference between gCA7B and a wildtype vims is the deletion in UL28. 
The region of the second mutation is fully functional in gCA7B. However 
gCA7B does not complement toZ47.
Similar information was also available to the original researchers. 
They found that toZ47 was able to complement almost every vims tested 
except two to mutants from HSV-2 that contained mutations in the UL28
TABLE 2
Virus Complementation between UL28 Mutants a
A7B tsTAl ts 1203
A7B -  0.54 0.38
tsZAl ~  11.19
ttl203
a Vero cells were infected (MOI=5) with pairs of viruses. Indices of 
complementation are shown in the table and are calculated using the 
formula: [titer of A+B] /  [(titer of A) + (titer of B)] as described in 
Materials and Methods. Values greater than 2.0 were considered 
positive.
gene region. If two mutations, each repairable to full wild type phenotype, 
existed in teZ47, then the only case in which complementation could fail 
would be a vims with two mutations in the same two critical regions. 
Therefore, the complementation results presented in this work are in 
agreement with previous efforts on tsTAl (Pancake et al., 1983; Addison et 
al., 1990).
Complementation results between tel203 and teZ47 are intriguing. It 
is known that tel203 has a mutation in UL28 and as stated above, teZ47 
also has a mutation in UL28. It is surprising that these two vimses are able 
to complement each other. Intragenic (allelic) complementation is not 
unknown, but is rather uncommon. It is possible that different functional 
domains exist within ICP18.5 and that these mutations lay in separate 
domains. The second hypothesis is that ICP18.5 participates in a dimer, 
multimer or complex. In both these hypotheses, aberrant proteins that are 
produced may still be able to function properly in viral replication when 
functional units coming from different vimses are combined. ICP18.5 has 
already been shown to participate in some sort of complex (Pederson and 
Enquist, 1991), and is thought to form a dimer or multimer (N. Pederson, 
personal communications).
There remains a question of whether the tmncated protein in gCA7B 
can participate in the complementation process. It was observed by 
Tengelsen et al., (1993) that no ICP18.5 could be detected in cells infected 
with gCA7B. It was suggested by these authors that the large deletion in the 
UL28 gene causes the protein to be unstable or rapidly degraded, because 
they could not detect ICP18.5 in immunoassays. Therefore in mixed 
infection with gCA7B it can be hypothesized that there is no second copy of
ICP18.5 to interact with the temperature sensitive protein of tel203 or 
teZ47.
Evidence presented in this chapter strongly suggest that a single 
mutation exists in the teZ47 vims. This mutation most likely lies in the 
UL28 gene. The original evidence of two mutations was based on results of 
marker rescue experiments. In the next chapter, molecular genetics 
experiments including marker rescue are presented in detail to further 
describe the mutation in teZ47.
CHAPTER 4 
MAPPING OF THE MUTATION IN fcZ47
Introduction
The vims was reported to be temperature sensitive for viral 
replication and expression of glycoproteins on the infected cell surface. 
In addition, marker rescue revealed two mutations in separate areas of 
the genome (Pancake et al., 1983). It is unusual that rescue of either 
mutation resulted in the wild type phenotype.
The concept of marker rescue is fundamental to genetic studies 
of double stranded DNA vimses (Coen, 1990). Purified total genomic 
DNA from herpesviruses and other double stranded DNA vimses can 
be transfected into permissive mammalian cells (Stow et al., 1978) and 
undergo transcription, and ultimately replication yielding infectious 
particles.
In marker rescue experiments total genomic viral DNA from the 
mutant vims is co-transfected with cloned wild type DNA fragments of 
representing portions of the vims genome (Stow et al., 1978). 
Recombination can occur in the cell between fragments of DNA that 
share homologous regions. If the wild type fragment is homologous to 
the mutated region, recombination can occur yielding a percentage of 
the progeny virus that have been rescued for the wild type gene and 
display the wild type phenotype. The percent yield is based on the 
efficiency of homologous recombination and the size of the DNA 
fragments used (Darnell et al., 1990).
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When marker rescue experiments were initially performed with 
tsZAl, the ts mutation was unexpectedly rescued by sequences 
representing two different regions of the HSV-1 genome (Pancake et 
al., 1983). The first region is approximately 2 kilobases (Kb) and is 
localized by overlap of the positive rescue of the EcoRI-C(JK) 
fragment and the Xbal-G fragment (Pancake et al., 1983). The overlap 
region is the far left end of the unique long segment of the genome and 
contains the long terminal repeats and the first 5 open reading frames 
(genes UL1-UL5). The second marker rescue experiment localized the 
mutation to the EcoRI-F fragment and the BglII-I fragment. This 
region is approximately 15 Kb (Pancake et al., 1983). These results 
have indicated that two possible mutations exist in the genome.
Results are presented here for marker rescue experiments that 
define the mutation in tsTAl to the UL28 gene alone. In addition, 
marker exchange and DNA sequencing experiments verify the presence 
of a single mutation in tsTAl.
Materials and Methods 
Cells and Viruses. Vero cells (Vero) and rabbit skin cells 
(RAB-9) were obtained from ATCC (Rockville, MD). Cells were 
maintained as described in Chapter 2. Vero cells were used to generate 
vims stocks, titer vims, and produce viral DNA. RAB-9 cells are a 
primary cell line which has been shown to take up DNA efficiently and 
were utilized in transfection experiments. HSV-1 (KOS) and (tsTAl) 
vimses were described previously in Chapter 2.
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Virus Infectivity Assay. Vims plaque assays were performed as 
described in Chapter 3.
Viral DNA. Infectious viral DNA was prepared in Vero cells as 
described previously (Kousoulas et al., 1984). Cells grown to 
confluency in 850 cm2 roller bottles were infected with a low MOI 
(0.01 PFU/cell). The infection was allowed to proceed until all of the 
cells were visibly rounded and nearly detached. Cells were shaken 
loose, collected by centrifugation, and lysed using 1% NP-40,0.5% 
DOC in 10 mM Tris, 1 mM EDTA (TE). The lysate was incubated on 
ice for 20 minutes then centrifuged at 15Q0»g for 10 minutes. The 
pellet was discarded and 25 pi RNase (10 mg/ml) per roller bottle of 
cells was added to the supernatant. This mixture was incubated for 15 
minutes at 60°C. After incubation 250 pi of 20% SDS and 100 pi 
Proteinase K (10 mg/ml) per roller bottle of cells were added and 
allowed to incubate for 2 to 3 hours at 65°C. The lysate was diluted to
15.5 ml with TE. Ethidium bromide (300 pi) and saturated Nal (24.5 
ml) were added to the lysate . This mixture was tested to insure a 
refractive index of 1.435 then transferred to ultracentrifuge tubes, 
balanced and sealed. Mixtures were centrifuged at 240,000*g for 36 to 
48 hours. Viral DNA bands were removed from tubes using a syringe 
with a 16 gauge needle and added to a second Nal gradient tube and the 
process was repeated. The second gradient was centrifuged for 20 to 
24 hours. Ethidium bromide was removed by extraction with 1-butanol 
and the DNA was dialyzed (in darkness) twice against TE and twice 
against T5E0.1 (5 mM Tris, 0.1 mM EDTA). Concentration of DNA
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was determined by UV spectrophotometry at 260 and 280 nm. DNA 
was stored frozen at -70°C.
Plasmids. A diagram of genomic location shows the relation­
ship between genes of interest and cloned DNA fragments (Figure 6). 
Plasmids pSGl, pSG18 are from a library of clones that contain EcoRI 
restriction fragments of HSV-1 (KOS) (Goldin et al., 1981). These 
clones span the entire genome and were a gift from Dr. R. Sandri- 
Goldin (University of California, Irvine, CA). Plasmid pRB2025, 
2024,2044, 2080, and 2081 are derived from HSV-1 (F), and were 
previously described (Kousoulas et al., 1984; Pellett et al., 1985). The 
cloning procedures used for generating the remaining clones designated 
pJC are described in detail in Appendix A.
Plasmid pJC2017 was used to generate numerous other plasmids 
and is drawn in Figure 7. Plasmid pJC2017 contains the HSV-1 (KOS) 
KpnI-N fragment generated from HSV-1 (KOS) viral DNA cut with 
Kpnl and cloned into the Kpnl site of pUC19 (Yanisch-Perron et al., 
1985). Restriction mapping and DNA sequencing verified the clone to 
be the KpnI-N fragment (Appendix B). Plasmid (pJC2025) was 
identical to pJC2017 except that it was generated from HSV-1 (tsTAl) 
viral DNA.
Truncated Plasmids. Plasmid pJC2017 was used to create a 
series of truncated deletions. Plasmids pJC2082,2083, and 2086 were 
generated from pJC2017 which was linearized at the 3' end using 
BamHI and then digested with Bal31 exonuclease (Sambrook et al., 
1989). Following digestion, the BamHI restriction site was restored 
using a BamHI linker (New England Biolabs, Beverly MA). Similarly,
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Figure 6. Plasmid Relationships to the HSV-1 Genome.
A. Top line represents the genome of HSV-1 (unique short region - 
Us ; unique long region - UL; inverted repeat regions - m ) .  Genes
UL28 and UL27 (gB) are reversed and expanded below the genome; 
heavy bars indicate coding region, and thin lines indicate promoter 
regions. Arrows below the genes indicate direction of transcription.
A bar indicates the mapped region of rescue for to 1203, and an asterisk 
indicates the point mutation in toZ47. B. The heavy line below the 
genes represents a cloned region from Sail to BamHI restriction 
enzyme (RE) sites. The small numbers indicate relative sizes of the 
cloned fragments, and the location of RE sites of interest. Fragments 
from truncated DNA clones are shown below the RE line. Clone 
names are shown in bold print. The hybrid nature of clone pJC2073 is 
delineated by a thick line representing KOS and a thin line representing 
the toZ47 portion. Vertical dotted lines indicate the boundaries of 
positive marker rescue experiments.
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Figure 7. Plasmid Map of pJC2017. Plasmid pJC2017 contains 
the KpnI-N restriction fragment from HSV-1 (KOS) cloned into the 
unique Kpnl site in the polylinker of pUC19. This plasmid was used for 
a series of both 5’ and 3’ terminal deletions as described in the text and 
shown in Figure 6.
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pJC2076 and pJC2081 were generated from pJC2017 that was 
linearized at the 5' end using EcoRI. Following digestion with Bal31, 
the EcoRI restriction site was restored using an EcoRI linker. The 
precise location of the tmncated deletions were determined by DNA 
sequencing (Appendix B). Plasmid pJC2073 was generated from both 
pJC2017 and pJC2025 with its 5' portion derived from pJC2017; H3V- 
1 (KOS) and the 3' portion from pJC2025; HSV-1 (tsTAl). These two 
DNA fragments were joined at the unique Nrul site forming a chimeric 
clone (Figure 6).
M arker Rescue and M arker Exchange Experiments. For 
rescue of the ts mutation, co-transfections were performed using cloned 
DNA fragments of HSV-1 (KOS) and total genomic viral DNA isolated 
from HSV-1 (tsTAl). RAB-9 cells were transfected with a modified 
calcium phosphate procedure (Chen and Okayama, 1987), which 
included a DEAE dextran treatment as described previously (Kousoulas 
et al., 1984). Cells were seeded 12 to 24 hours prior to co-transfection 
to achieve 30 to 50% confluency at the time of DNA transfection.
Prior to transfection the cells were washed with TEN (Tris, 10 mM; 
EDTA, 0.1 mM; NaCl, 147 mM) and treated for 1 minute with DEAE 
dextran (200pg/ml in TEN).
A precipitate of calcium phosphate and DNA was formed by 
combining: plasmid DNA (20 ng - 2 jig), viral DNA (20 ng - 200 ng),
2.5 M CaCl2 (to a final concentration 0.156 M) and 2x BBS (equal to
one-half the final volume). BBS contains normal saline buffered to 
pH 6.9 with BES (2-[bis(2-Hydroxyethyl)amino]ethanesulfonic acid) as 
described by Sambrook et al., (1989).
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The precipitate was allowed to form for 45 minutes following the 
addition of the BBS. Medium containing 10% serum was added to the 
precipitate (1 ml) following the incubation period. The precipitate was 
then added to prepared cells and incubated for 4 hours at 37°C and 
5%CC>2. The precipitate was aspirated from cells and phosphate-
buffered saline (PBS) containing 15% glycerol was added to the cells 
(1 ml per well) for 1 to 2 minutes. Cells were then washed two to three 
times in medium without serum and fresh media containing 10% serum 
was added to each well.
Cells were allowed to recover undisturbed for 12 hours, then the 
medium was removed and replaced with fresh medium. This process 
removed dead cells and helped to insure that all the remaining CaCl2 
was removed from the culture. Cells transfected with viral DNA 
showed cytopathic effects beginning at 48 to 72 hours post transfection. 
The infection was allowed to progress until all cells were infected. 
Stocks were made from the transfected cells, and duplicate titer plates 
were incubated at 34°C or 39°C as described previously. Rescue 
frequencies were calculated as (PFU at 39°C)/(PFU at 34°C) x 103 as 
previously described (Pancake et al., 1983). This ratio of virus at 39°C 
versus virus at 34°C allowed us to determine whether rescue of the wild 
type marker had occurred.
To restore the mutation into the genome, cloned DNA from 
HSV-1 (tsTAl) representing the BamHI-G restriction fragment 
(approximately 9 kilobase pairs in length) was transfected into Vero 
cells for marker exchange. Transfection was performed as described 
above except that a higher level of DNA was used (10-50 pg). Cells
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were infected 18 to 24 hours post-transfection with HSV-1 (gCA7B) at 
a MOI of 5 PFU/cell. Mock transfections (without DNA) followed by 
infection were used as controls. Viral stocks were made at 48 to 72 
hours post-infection. These stocks were initially examined for any 
temperature sensitive phenotype. Stocks displaying any temperature 
sensitivity were plated out for plaque selection. Plaques were isolated 
from these stocks and assayed for ability to grow on Vero cells, and for 
temperature sensitive replication at 34°C versus 39°C. Isolated plaques 
which displayed temperature sensitivity were picked and plaque 
purified three times under agarose overlay. The agarose overlay 
prevents the spread of virus through the liquid medium, and increases 
the probability of selecting a plaque which developed from a single 
vims isolate.
DNA Sequencing. Fragments of viral DNA from KOS or tsTAl 
were cloned into pUC19 (Yanisch-Perron et al., 1985). Double 
stranded DNA sequencing (Dideoxy sequencing) was performed using 
the Sequenase®2.0 kit (United States Biologicals, Cleveland, OH) as 
instructed by the manufacturer with the following modifications (1) 
DNA was denatured using 0.4 M NaOH, and 0.2 mM EDTA, (2) 
templates and primers were annealed in the presence of 5% dimethyl 
sulfoxide (Bachman et al., 1990), (3) labeling reactions were carried 
out at room temperature using 35S-ATP (specific activity 12.5 mCi/ml; 
NEN®-Dupont, Boston, MA), (4) single strand binding protein (USB, 
Cleveland, OH) was also added during the labeling step, and (5) the 
termination reaction was carried out at 45°C using 7-deaza-guanosine 
dideoxynucleotides to reduce base stacking.
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Template DNA consisted of both cloned DNA fragments from 
tsTAl and KOS, as well as genomic viral DNA that had been tested in 
transfection assays to verify its identity. Primers were designed and 
synthesized in our laboratory on a Cmachem® Oligonucleotide 
synthesizer. Primer sequences were based on published sequence for 
HSV-1 (17) (McGeoch et a l, 1988). Primers are described in detail in 
Appendix C.
Samples were stored frozen at -20 °C until electrophoresis. Prior 
to electrophoresis, samples were thawed and boiled for 3 minutes, then 
placed on ice. Electrophoresis was performed using, Gel-Mix®6 
(Gibco-BRL), containing Acrylamide : N,N'-methylenebisacrylamide 
(5.7% : 0.3%), 7 M urea in a Tris-borate-EDTA buffer (pH 8.3). 
Samples (3 pi) were loaded between lanes of a sharks-tooth comb and 
gels were run at constant voltage of 2000-2200 volts for 1.5 to 2 hours. 
The gels were fixed using 10% methanol in water, and dried on a 
vacuum gel drying apparatus prior to being autoradiographed for 18 to 
48 hours. Sequence data from autoradiographs were recorded and 
analyzed using the MacVector software program (IBI-Kodak, New 
Haven, CT).
Results
M arker Rescue. The theoretical value for maximum rescue 
efficiency is calculated to be 1000, because there should be no 
difference in vims growth for the wild type KOS vims between 34°C 
and 39°C (titer at 39°C / 34°C x 1000). A rescue efficiency of 1 
reflects a three log decrease in titer between 34°C and 39°C for tsTAl.
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Rescue efficiencies less than 50 were considered negative to account 
for possible variation in viral titers at 34°C and 39°C.
Plasmids pSG18, pRB2024, 2044, pJC2017, 2083, and 2086 
efficiently rescued the ts mutation, while plasmids pRB2025, and 
pJC2082 produced a low frequency of rescue. Plasmids pRB2081, 
pRB2080, pJC2076, and pJC2081 however, failed to rescue the ts 
mutation (Table 3). The DNA region containing the mutation was 
defined by the overlap of plasmid clones pJC2017 at the 5' termini and 
pJC2082 at the 3’ termini (Figure 6). The chimeric plasmid pJC2073 
also rescued the ts mutation and thereby narrowed the search to a 1333 
base pair region, as defined by the restriction enzyme sites Kpnl and 
Nrul as shown in Figure 6.
Multiple marker rescue experiments were also performed using 
the library of cloned EcoRI fragments described in the Materials and 
Methods, which spanned the HSV-1 genome. Plasmid pSG18, 
containing the HSV-1 DNA fragment EcoRI-F, was the only clone 
from this library that successfully rescued the ts phenotype of tsZAl. 
Special attention was paid to plasmid pSGl (EcoRI-J+K) that was 
previously reported to rescue tsZ47 (Pancake et al., 1983). However 
pSGl failed to rescue /.sZ47 in seven out of seven experiments.
M arker Exchange. Experiments were undertaken to exchange 
the ts mutation of tsTAl for the UL28 deletion gene in gCA7B.
Plasmid DNA containing the cloned BamHI-G fragment of tsTAl was 
transfected into Vero cells and these cells were superinfected with 
gCA7B virus. Stocks from this initial experiment yielded 10-fold more 
viral plaques on Vero cells at 34°C compared to stocks from mock
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TABLE 3
Marker Rescue Data from Co-transfection of 
Plasmids with Intact Viral DNA
PFU/mla  Efficiency
Virus 34 °C 39 °C of Rescue6
K O Sc 1.0 x lO 10 6.6 x lO 9 660.0
tsT A ld  1.1 x 107 1.0 x lO 5 9.1
pSG18 3.1 x 105 1.5 x lO 5 483.9
pRB2081 7.6 x 106 1.2 x lO 5 15.8
pRB2080 2.0 x 106 4.0 x lO 4 20.0
pRB2025 1.1 x 107 1.0 x lO 6 90.0
pRB2024 2.0 x lO 5 1.9 x lO 5 950.0
pRB2044 6.0 x 105 1.6 x lO 6 2666.7
pJC2017 7.6 x 106 5.7 x 106 755.0
pJC2076 2.0 xlO 4 3.0 x 102 15.0
pJC2081 5.0 x lO 7 1.4 xlO 4 0.3
pJC2082 8,0 xlO 6 8.5 x 105 106.3
pJC2083 3.1 x 105 4.4 x 105 1442.6
pJC2086 2.8 x 105 1.3 x lO 5 464.3
pJC2073 4.5 x 106 2.6 x 106 1730.0
a Virus was collected 72 to 96 hours following co-transfection and 
titered on Vero cells at 34°C and 39°C expressed as PFU/ml.
^ Efficiency of rescue is expressed as (PFU 39°C) /  (PFU 34°C) x 1000 
(Pancake et al., 1983).
c Positive control for marker rescue phenotype (wild type).
d Negative control for marker rescue phenotype.
e Rescue efficiencies of greater than 50.0 were considered positive.
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transfection infection control. However, when these same two stocks 
were grown at 39°C, no difference in titer was observed. This 
indicated the presence of temperature sensitive virus in the experi­
mental virus stock. Isolated plaques were picked under a 0.5% agarose 
overlay, and tested for temperature sensitivity. A single virus was 
isolated following three rounds of plaque purification. The titer of the 
purified virus on Vero cells was 6.2 x IQ6 at 34°C and 1.4 x 103 at 
39°C (average of three experiments), indicating a temperature sensitive 
phenotype had been restored using the tsTAl BamHI-G cloned DNA 
fragment.
DNA Sequencing. To identify the ts mutation, the mapped 
DNA region was sequenced. The sequence of HSV-1(17); GenBank 
accession # D00317 (McGeoch et al., 1988), was used for reference 
purposes. A partial DNA sequence of the HSV-1 (KOS) UL28 gene 
had been previously reported and was also used; GenBank accession # 
K01760 (Bzik et al., 1984). However, it was necessary to sequence 
both the mutant strain tsZ47 and the parent strain KOS to determine the 
site of the mutation. A single point mutation between tsZ47 and KOS 
was discovered within the mapped region. This was verified by 
sequencing both DNA strands (Figure 8).
In this region of the gene, strains KOS and reference strain 17 
had identical DNA sequences except for the point mutation. The 
mutation was identified as a thymidine (T) to cytosine (C) change in 
the coding strand at position 1576 of the UL28 gene (1 = "A" in ATG 
at start of UL28). This point mutation is predicted to specify an
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Figure 8. DNA Sequencing Results. Autoradiograph of portions of a 
DNA sequencing gel showing the ts mutation in HSV-l(toZ47) and 
homologous HSV-1 (KOS) wild type sequence. Sequence ranges from 
nucleotides 1567 to 1582, with the mutation (*) occurring at nucleotide 
1576 (1 = "A" in ATG start of UL28 coding region).
63
arginine (R531) to tryptophan (W531). change in ICP18.5 of HSV-1 
(17).
The impact of this mutation on the predicted local secondary 
structure of ICP18.5 was analyzed with the MacVector software (IBI- 
Kodak) and GCG mainframe programs (Devereux et al., 1984). Chou- 
Fasman and Robson-Gamier analyses (Chou and Fasman, 1974; 
Gamier et al., 1978) showed that the region surrounding the mutation is 
predicted to form an alpha helix (Figure 9). The region in which the 
mutation occurs is within an arginine-rich domain which is highly 
conserved among different herpesvirus genomes (Figure 10). A helical 
wheel profile (Devereux et al., 1984) applied to this region, places the 
charged residues (mostly R) together on one third of the wheel, and no 
charged residues occur elsewhere on the helix (Figure 11).
Discussion
Marker rescue experiments previously indicated the existence of 
a second mutation located in the left end of the HSV-1 genome (UL1- 
UL5). However, the extensive attempts at marker rescue reported here 
failed to indicate the presence of a second mutation. The original 
experiments (Pancake et al., 1983) utilized two DNA fragments. One 
that was purified by electrophoresis through agarose. This fragment 
may have been contaminated with other viral DNA fragments 
containing the UL28 gene, which could account for the positive rescue 
results. The second fragment was the EcoRI-C (J+K) cloned fragment 
designated pSGl. The same clone which failed to rescue in all
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Figure 9. Secondary Structure Predictions. Analysis of the region 
of the mutation in tsZ47 compared to the parent strain KOS. Analyses 
were performed using the "Protein Toolbox" application of the 
MacVector Software (IBI-Kodak). Predicted amphiphilic helices are 
represented in the top graphs, and predicted secondary structure in the 
bottom graphs. CF - Chou-Fasman, RG - Robson-Gamier.
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Figure 10. ICP18.5 Protein Segment Comparison Among Herpesviruses. Comparison of segments of 
ICP18.5 homologs, equine herpesvirus type 1 (EHV-1), pseudorabies virus (Suid herpesvirus type 1; 
PRV), bovine herpesvirus type 2 (BHV-2), human herpesvirus type 1 (HSV-1) strains Angelotti (ANG), 
F, KOS, and mutant tsTAl. The conserved arginine residue, and mutation to tryptophan are shown in bold. 
Arrows beneath the sequences indicate charged residues.
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Figure 11. Helical Wheel Profile of the Conserved Region of 
ICP18.5. The polypeptide region of ICP18.5 shown in Figure 9 was 
applied to helical wheel analysis using GCG Software program "Helical 
Wheel". Amino acid residues surrounded by a box are hydrophobic.
W is Substituted for R at the circled amino acid position.
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experiments reported here. DNA sequence analysis in our laboratory 
confirmed the plasmid to be pSGl.
With the exchange of the deleted UL28 gene of gCA7B for the 
temperature sensitive UL28 gene of tsTAl, the phenotype of tsTAl (3 
log drop in titer at 39°C) was successfully restored. The marker 
exchange experiment adds significant support to the hypothesis that a 
single mutation exists in tsTAl. Future testing of this mutant will 
include evaluation of glycoprotein transport to the cell surface, and 
other phenotypic parameters which define the mutant virus.
DNA sequencing of this region of the HSV-1 genome was partic­
ularly difficult due to the high G-C content (69-71%). High percentage 
of G and C bases results in compressed sequence data and shorter 
readable sequences with a large number of strong stops in all four 
reading lanes. A large number of primers were constructed to sequence 
small regions and sequencing had to be repeated many times to 
evaluate the results. As described in the Materials and Methods, 
several unique methods were used to alleviate problems relating to the 
G-C content of the genome. Although most modifications had been 
reported individually previously this is the first time they have been 
used in conjunction with one another.
Once a single mutation was discovered a number of computer 
assisted analyses were performed to attempt to better understand the 
role of this gene in vims growth. Computer predictions of secondary 
structure of proteins based on sequence information are at best only 
60% accurate. Therefore evidence discussed here must only be 
considered speculative. The mutation results in a tryptophan (W) being
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substituted for an arginine (R). The substitution occurs in a region that 
is particularly high in R, and is extremely conserved among herpes­
viruses. Arginine rich regions have been previously implicated in DNA 
binding by the hepatitis B virus core protein (Nassal, 1992). The 
region surrounding the mutation is predicted to be an alpha helix, but 
the mutation causes a increase in probability of a sheet motif. This 
region of UL28 does not conform to a predicted helix-tum-helix motif, 
but may form a helix-loop-helix domain (Murre et al., 1989). The 
change from R (basic, hydrophilic and charged) to W (hydrophobic and 
aromatic) is rather drastic and occurs near the carboxy terminus of a 
predicted alpha helical region in the UL28 protein. Arginine residues 
at the carboxy terminus of a helix-loop-helix domain were shown to be 
critical for DNA binding (Murre et al., 1989). A histone kinase 
phosphorylation site, R-X-S (Carstens and Weller, 1979) is also 
predicted to be absent in the mutated UL28 protein.
Once the location of the mutation was known, experimental 
evidence was re-examined. The positive complementation results 
between toZ47 and to 1203, might now be better explained. The 
mutation in to 1203 had been mapped to the 5' region of the UL28 gene 
(Addison et al., 1990). This region is distinct from the mutation in 
toZ47. They are separated by between 866 and 1359 bp. It remains 
likely that ICP18.5 has domains that are functionally distinct, or that it 
forms dimers or multimers since the regions of mutation are separate. 
After finding the mutation and studying some of the predicted 
properties of the protein, experiments were performed that examined 
the physical and phenotypic effects of this mutation on viral replication.
CHAPTER 5
EXAMINATION OF DNA CLEAVAGE AND PACKAGING AND 
ELECTRON MICROSCOPIC EVIDENCE OF 
THE MUTATION IN &Z47
Introduction
The mutation in HSV-1 (tsTAl) was found to be located in the 
unique long gene (UL28) and to cause defects in viral replication at the 
nonpermissive temperature. Recent reports indicate that the UL28 gene 
may be involved in cleavage and packaging of viral DNA (Addison et 
al., 1990; Mettenleiter et al., 1993; Tengelsen et al., 1993). In addition, 
there are four other HSV-1 genes currently known to be required for 
cleavage and encapsidation, which include: UL6, UL25, UL32 and 
UL33 (Addison et al., 1984; Sherman and Bachenheimer, 1987; Sher­
man and Bachenheimer, 1988; Addison et al., 1990; Al-Kobaisi et al., 
1991). The exact role that the product of each of the genes plays is not 
understood. Experiments were designed to elucidate the physical 
effects of the tsZ47 mutation on viral replication.
The ability of the virus to cleave concatemeric strands of DNA 
was examined first. DNA produced during rolling circle replication 
must be cleaved into unit genomic length before packaging into the 
capsids (Roizman, 1991). Long concatemers of DNA lack the free ends 
that are present on unit copy genomes. The terminal repeat regions at 
the free ends are identical to the internal repeat regions which form the 
junction of the unique long and unique short segments of the genome
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(Roizman, 1991). A DNA probe was used (plasmid pSGl) that would 
bind to the free ends and to the homologous region at die U l  and Us 
junction (Figure 12). This probe was radiolabeled and used in Southern 
blot analysis to determine whether or not DNA was being cleaved to 
unit length in the mutant virus.
To clarify the question of packaging of DNA into nucleocapsids, 
infected cells were examined using electron microscopy. Capsids and 
vims particles were examined in the nuclei of infected cells. Com­
parisons were made between wild type and the temperature sensitive 
viruses at both the permissive and the nonpermissive temperatures
In this chapter, it is reported that tsTAl does not properly cleave 
DNA into genomic lengths at the nonpermissive temperature, nor does 
it package DNA into capsids. In addition, a unique capsid structure is 
observed and described.
Materials and Methods 
Cells and Viruses. Vero cells, described in Chapter 2, were 
used to generate vims stocks, titer vims, generate DNA for the cleavage 
and packaging studies, and for electron microscopy studies. HSV-1 
(KOS), tsZAl and UL28-null vims, gCA7B, have been described 
previously in Chapters 2 and 3.
Virus Stocks. Stocks were prepared as described in Chapter 2. 
Viral DNA Extraction. For analysis of DNA cleavage and 
packaging, total DNA was extracted from infected Vero cells as 
described previously (Addison et al., 1990; Tengelsen etal., 1993).
Vero cells were infected with either tsTAl or KOS at a MOI of 5
32-P*
Probe
A.
12.7 KBp 18 21 KBp 5.3  KBp
IWWWVI
18-21 KBp
Figure 12. Location of Probe and Homologous Termini. The location of 
the nick translated 32P probe is shown beneath the HSV-1 genome. The EcoRI 
restriction fragment pattern which would result from cleavage of DNA into unit 
lengths (A) and without cleavage (B) are shown below the genome and probe.
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PFU/cell. These cultures were then incubated at either 34°C or 39°C, 
the permissive and nonpermissive temperatures, respectively. As a 
control, gCA7B was used to infect either Cl or Vero cells (permissive 
and nonpermissive cells) at a MOI of 5 PFU/cell. This control infection 
was incubated at 37°C. Infected cells were harvested in 1 to 2 days, 
when all cells displayed full cytopathic effects (CPE) of the viral 
infection.
To obtain total viral DNA, the cells were lysed (0.6% SDS; 10 
mM EDTA; 10 mM Tris-HCl pH 7.5; 500 |ig/ml proteinase-K), and 
incubated at 37°C for 4 to 6 hours. DNA was purified by a phenol/ 
chloroform extraction and ethanol precipitation, and resuspended in TE.
Southern Blot Hybridization. Purified DNA was digested to 
completion with EcoRI and electrophoretically separated in a 0.6% 
agarose gel. DNA bands in the agarose gel were visualized using 
ethidium bromide staining, and photographed to determine relative 
mobility. DNA was depurinated by soaking the gel for 15 minutes in
0.25 M HC1. The gel was then transferred to a bath containing 0.5 M 
NaOH and 1.5 M NaCl for 15 minutes to denature the DNA. The gel 
was neutralized for an additional 15 minutes in a bath containing 1.0 M 
Tris-HCl (pH 8.0) and 1.5 M NaCl. The DNA was then transferred 
from the gel to a nitrocellulose or nylon membrane using a vacuum 
transfer apparatus (Hoefer, San Francisco, CA) and 25 mM sodium 
phosphate (pH 6.5) as the transfer buffer. The nucleic acids were cross- 
linked to the membrane by baking at 100°C for 1 hour (nitrocellulose), 
or by UV cross-linking (nylon membrane). Blots were prehybridized 
using 6X SSC, 2X Denhardts (Sambrook et al., 1989), 30% formamide,
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and 200 jag/ml sheared salmon sperm DNA according to standard 
methods (Southern, 1975) to block all nonspecific binding sites on the 
membrane. While this was occurring, plasmid pSGl was nick- 
translated using 32P dCTP (NEN-Dupont, Wilmington, DE) according 
to the protocol of the manufacturer. One microgram of purified DNA 
was incubated with 100 pCi of y-32P dCTP along with unlabeled dGTP, 
dATP and dTTP in the presence of DNA polymerase I. A small 
amount of DNase I was added to cause random nicking of the plasmid 
DNA. Nicks were repaired by DNA Polymerase which incorporated 
the radiolabeled nucleotide. This radiolabeled probe was added to the 
blot and incubated for 18 hours at 68°C for hybridization (Post et al., 
1980) in a rolling bottle hybridization chamber (Robbins Scientific, 
Sunnyvale, CA). The blot was washed repeatedly in 2X SSC, followed 
by washes in the prehybridization solution in which the level of 
formamide was reduced to 20%. The damp membrane was then 
wrapped in plastic wrap and used to expose X-Omat AR film (Eastman 
Kodak, Rochester, NY) to obtain the autoradiograph. Additional 
washes were performed as necessary to remove background 
contamination.
Electron Microscopy. Vero cells were grown in 60 x 15 mm 
Nunc Permanox® dishes (a special plastic for electron microscopy 
processing). Cells were infected with vims at a MOI of 10 PFU/cell.
At 12 hours post-infection, cells were fixed in situ with 1.25% 
glutaraldehyde and 2% formaldehyde in 0.1 M sodium cacodylate 
(CAC). Samples were transferred to the electron microscopy facility at 
the School of Veterinary Medicine for further processing. Briefly,
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fixed cells were washed six times in 0.1 M CAC + 5% sucrose and 
fixed with 1% osmium tetroxide in 0.1 M CAC. Cells were dehydrated 
using gradient steps of ethanol, then infiltrated with propylene oxide 
and polymerized for 48 hours. Sample blocks were thin sectioned, 
mounted on grids and stained for 15 minutes with uranyl acetate and 
lead citrate (McCombs et al., 1968; Atkinson et a l, 1978). Sections 
were examined using a Phillips 410 electron microscope. A minimum 
of five sections were examined for each virus and temperature.
Results
Cleavage of DNA. The results of Southern blot hybridization 
with the pSGl probe specific for the junction region of the HSV U l and 
Ug are depicted in Figure 13. The pSGl plasmid used as the probe 
contains the EcoRI-C (J+K) fragment. The probe will detect DNA 
fragments containing the J or K sequences. Due to the isomerization of 
the genome this will result in a pattern of bands; J+K (18.0 Kbp), E+K 
(21.4 Kbp), J (12.7 Kbp), and K (5.3 Kbp) when concantemeric DNA is 
cleaved with EcoRI. However, in the absence of proper cleavage the 
free ends of the genome, J and K, will be absent or present in signif­
icantly reduced amounts. Analysis of tsTAl at the permissive 
temperature showed normal cleavage of genomic DNA, yielding the 
expected bands (Figure 13, Lane 2). However, when grown at 39°C, 
the 12.7 and 5.3 Kbp bands were absent, indicating lack of cleavage 
(Figure 13, Lane 5). Virus gCA7B was included as a control since it 
fails to cleave and package viral DNA in Vero cells (Tengelsen et al., 
1993).
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Figure 13. DNA Cleavage Analysis. Vero cells were infected with KOS 
(lanes 1 and 4) or tsTAl (lanes 2 and 5). Cells were incubated at 34°C 
(lanes 1,2) or 39°C (lanes 4,5). UL28-null virus, gCA7B was used to 
infect Cl cells (lane 3) or Vero cells (lane 6) as a control. Cells were 
collected and processed for total genomic and viral DNA. DNA samples 
were digested with EcoRI, and separated on a 6% agarose gel, then 
transferred to nylon membrane. 32P labeled pSGl plasmid DNA was 
hybridized to the DNA on the membrane. The size (kilobase pairs, Kb) 
of major hybridization bands are indicated to the left of the photograph.
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Electron Microscopy. Examination of the electron micro­
graphs revealed a distinct difference between infections with tsTAl and 
KOS. There were no substantial differences for wild type KOS grown 
at 39°C (Figure 14a) or 34°C (data not shown). Capsids were observed 
in the nucleus corresponding to empty (type A ), partially filled (type 
B), and fully filled. Enveloped capsids (type C) were also visible in 
the cytoplasm and adjacent to the infected cells. The number of empty 
or partially filled capsids present in the nucleus was slightly higher for 
KOS when grown at 39 compared with 34°C (data not shown). In 
Figure 14b, tsTAl vims particles formed at 34°C displayed a range of 
maturation from empty to fully filled capsids. The empty capsids, 
however, were characterized by a stippled "soccer ball" appearance. 
Dark staining points are visible within or as part of the capsid. The 
tsTAl vims grown at 39°C revealed a similar morphology although no 
fully filled capsids were visible within the nuclei (Figure 14c). 
Randomly distributed, but not arrayed, empty capsids in the nuclei were 
observed in micrographs of tsZAl infected cells at both temperatures 
(data not shown). A higher magnification micrograph of the "soccer 
ball" morphology is shown in Figure 14d.
Discussion
Temperature sensitive mutant vims tsZAl contains a single 
mutation located in the carboxy terminus of the UL28 gene. As 
indicated by the Southern blot hybridization, tsTAl fails to cleave DNA. 
This is in agreement with previous reports regarding HSV-1 UL28 and 
the UL28 homologs of pseudorabies virus (Addison et al., 1990;
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Figure 14. Electron Micrographs of HSV-1 Infected Cells. N
(nucleus) and C (cytoplasm) and a scale bar (0.5 pm) are indicated on 
each micrograph. A. Array of capsids in the nucleus of a Vero cell 
infected with KOS at 39°C in varying stages of filling. An open arrow 
indicates an empty capsid, and a small solid arrow indicates a full 
capsid. Enveloped full capsids (large solid arrow) are visible in the 
cytoplasm. B. tsTAl grown at 34 °C shows an array of capsids in the 
nucleus. Empty capsids (open arrow) and filled capsids (solid arrow) are 
both visible in the nucleus. Note the stippled "soccer ball" appearance of 
the empty capsids at permissive temperature. A partially enveloped 
empty capsid is visible between lamellae of the nuclear membrane (large 
solid arrow). C. Vims tsTAl grown at 39°C; only empty capsids (open 
arrow), with the characteristic stippled appearance are visible within the 
nucleus . The degenerating nucleus is shown leaking capsids to the 
cytoplasm (large solid arrow). D. Higher magnification of tsTAl at 
39°C showing the "soccer ball" appearance of empty capsids.
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Mettenleiter et al., 1993; Tengelsen et al., 1993). Cleavage of DNA is 
likely to be an enzymatic function and in some viruses this is 
accomplished by a topoisomerase. ICP18.5 does not conform to any 
known proteins currently available for comparison in GenBank, PIR or 
SwissProt databases and special attention was paid to topoisomerase 
and other DNA binding or cutting types of enzymes. The exact role of 
ICP18.5 in the process remains to be elucidated.
Careful examination of previous published work revealed that 
tel203 produces randomly scattered, partially filled capsids throughout 
the nucleus (Addison et al., 1990), and gCA7B produces empty capsids 
randomly distributed throughout the nucleus (Tengelsen et al., 1993).
In infections with tsTAl at the nonpermissive temperature we noted 
distinct types of virion particles. Some were identical to tel203 and 
gCA7B while others were properly arrayed but had stippled "soccer 
ball" appearances exhibiting a maximum of four electron dense patches. 
The array of capsids has long been thought to be a step in proper 
assembly and packaging. The stippled appearance may be the result of 
improper assembly of capsids, or improper packaging of DNA. This 
stippled appearance has not been reported before for herpes simplex 
type 1, but may be similar to the cylindrical cores inside capsids 
reported by Schaffer et al., (1974). Similar structures were described 
for equine herpesvirus type 1, as well as maleagrid herpesvirus of 
turkeys (Perdue etal., 1976). These capsids were described as having a 
"translucent cross" and were observed in wildtype infections in low 
amounts. They were attributed to the different stages of morphological 
development of the capsids (Perdue etal., 1976). Various planar
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figures may be generated if the thin sections cut through the capsid at 
odd angles. The cross section might appear as a dot if the DNA were 
present in a cylinder instead of a torus (Perdue et al., 1976). 
Alternatively, DNA may be associated with the vertices of the capsid 
without entering into the capsid, creating electron dense dots along the 
capsid vertices.
Importantly, Vero cells infected with gCA7B displayed only 
partially filled (type B) capsids in the nucleus and enveloped B capsids 
in the cytoplasm which lacked a distinct tegument layer. A similar 
partially enveloped particle was shown at the permissive temperature in 
Figure 14b, however, enveloped particles in the cytoplasm at the non­
permissive temperature in infections with tsTAl were not observed. It 
remains to be clarified whether the absence of UL28 protein in gCA7B 
is responsible for envelopment of empty capsids.
In all cases there was a diminished number of type A capsids 
(empty). It has been proposed before that type A capsids are a decay 
product and not part of the natural maturation process. Certain 
temperature sensitive mutants that fail to cleave or package DNA are 
noticeably deficient in type A capsids suggesting that they are formed 
subsequent to the filled capsids (Sherman and Bachenheimer, 1988). 
Observing differences in the electron micrographs between these 
various mutants defective in cleavage and packaging suggests that there 
may be a temporal or stepwise pattern to the assembly of the complete 
capsid and packaging of DNA prior to egress.
In summary, tsTAl contains a single mutation that results in a 
defect in cleavage of concatemeric DNA into genomic lengths and a
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failure to package DNA into capsids. Considering the presence of at 
least four other ts mutants in cleavage and packaging, and the previous 
data which suggests UL28 can be found in a complex, it is plausible 
that more that one viral protein is responsible for the events necessary 
to cleave and package DNA. The discovery of this cleavage complex 
would be important to the study of herpesviruses and could lead to 
development of in vitro systems for packing and delivery of DNA.
CHAPTER 6 
SUMMARY OF SIGNIFICANCE AND 
IMPLICATIONS FOR THE FUTURE
Summary and Significance of Research
Although the overall goal of this project has always been to 
characterize the herpes simplex type 1 temperature sensitive mutant 
teZ47, the research has taken a number of twists with respect to the 
hypothesis and the conclusion. In the beginning, the search was for a 
protein involved in transport of glycoproteins to the cell surface. 
However, evidence accumulated which showed a normal pattern of 
glycoprotein synthesis and transport. In addition, questions arose 
regarding the number of mutations in the virus. Through the use of 
cellular and viral complementation, we were able to conclude that a 
single mutation existed in teZ47 unique long open reading frame 
(UL28).
The marker rescue and marker exchange data also point toward a 
single mutation rather than two mutations existing in teZ47 and confirm 
the complementation data. This mutation is located in the UL28 gene, 
and has been identified by DNA sequencing to be a C to T transversion, 
which results in an amino acid substitution of R to W. Speculation 
using computer predicted analysis of the secondary structure of 
ICP18.5 suggests that the mutation occurs in a conserved R-rich region 
and may interrupt a region important for charged interactions. From 
evidence presented in previous sections, it can also be concluded, that 
the mutations in tsZA7 and tel203 are distinct, and the
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complementation observed is allelic in nature indicating that ICP18.5 
has different functioning domains, or may participate as a dimer or 
multimer.
Finally we assessed the physical effects of this mutation on viral 
replication. Examination of the DNA produced during infection at the 
nonpermissive temperature revealed that DNA was not being cleaved to 
unit length, but was remaining as long concatemers. This was similar 
to another temperature sensitive mutant virus in UL28, ts1203.
Electron micrographs were also examined and revealed an absence of 
filled capsids in cells infected with tsZAl at the nonpermissive 
temperature. In addition, an intriguing capsid structure, described as a 
stippled or soccerball appearance was observed in all cells infected with 
tsZAl.
Prospectives for Future Research
Identification of the mutation in tsTAl has raised new questions 
regarding the ability of herpesviruses to package and produce infectious 
progeny. Future research in this area will help to more thoroughly 
elucidate the basic biology of HSV-1 and possibly lead towards in vitro 
systems for assembly and packaging of tailored DNA constructs for 
delivery into mammalian cells. It may be possible to reconstruct such a 
system or complex from the necessary components for evaluation of 
cleavage and packaging. Described below are some proposed 
experiments which might further delineate the role of UL28 in the 
cleavage and packaging process.
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1. Create deletion viruses in each of the five genes involved in 
cleavage and packaging. Cell lines containing those same gene to 
propagate viruses with homologous gene deletions. Currently, 
temperature sensitive mutant viruses exist for the five genes but 
deletion mutants allow for a more complete assessment of the role of 
each protein. Cell lines containing individual genes can be used as 
described previously to complement a missing or defective viral 
function in a temperature sensitive virus. In addition, these cell lines 
allow for the propagation of vimses that have an essential gene deleted 
from the genome. Deletion of essential genes is only possible when the 
function can be complemented in trans from a transformed cell line.
2. Examine the step-wise pattern of cleavage and packaging 
using these viruses and cell lines in reconstruction experiments. It may 
also be possible to substitute expressed protein or purified infected cell 
extracts for essential genes. In this manner the minimal system needed 
for complete packaging can be assessed. Proteins required are added 
together in combinations and groups to determine the temporal 
regulation of cleavage and packaging. Preformed capsids can be 
isolated from specific mutants and used as vessels for packaged DNA.
3. Attempt to characterize the complex involved in cleavage 
and packaging and any other associated proteins; possibly 
accomplished using immunoprecipitation. It has been suggested that 
UL28 forms complexes in infected cells. Purification and identification 
of the components of that complex would help to determine the role of 
specific proteins in the process of cleavage and packaging.
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4. Reconstruct an in vitro system utilizing purified proteins that 
cleave viral DNA. The long range goal would be to develop the 
necessary components for an in vitro system for packaging of non-viral 
DNA into assembled capsids.
In conclusion, the research effort described here has clarified the 
genotype and phenotype of temperature sensitive mutant virus HSV-1 
(teZ47) and found a single mutation in the UL28 gene which appears to 
play a role in cleavage and packaging of viral DNA. There remains an 
intriguing question as to whether ICP18.5 acts alone or is involved in a 
dimer, multimer or complex. Evidence of intragenic (allelic) comple­
mentation with HSV-1 (tel203) suggests that UL28 has at least two 
domains which function independently. Further examination of UL28 
and the other genes involved in cleavage and packaging of viral DNA 
may lead to a better understanding of the cleavage and packaging 
process in herpesvirus replication and maturation.
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APPENDIX A
CLONED DNA FRAGMENTS
pJC 2017
pJC 2019
pJC 2025
pJC 2072
pJC 2073
pUC19 vector, insert is KpnI-N fragment of HSV-1 
(KOS) from agarose gel (lowmelt) purified viral DNA.
pK18 vector, insert is BamHI-G fragment of HSV-1 
(KOS) from agarose gel (lowmelt) purified viral DNA.
pUC19 vector with KpnI-N fragment of HSV-1 (ts78), 
cloned in the forward orientation. This clone was later 
found to be a double (head to tail) insert and recloned for 
a single insert (see clones pJC 2070-2071). Still usable 
for sequencing, subcloning and marker rescue/transfer.
Hybrid clones. Entire Kpn-N fragment regenerated from 
[KOS: NruI->EcoRI] and [ta78: EcoRI->NruI]; thus the 
clone has a 5' end from ts78 and a 3’ end from KOS.
The junction is at the Nrul site.
Same as 2072 but the order is switched. 5' end is from 
KOS and the 3' end is from ts78. The junction remains at 
the Nrul site.
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pJC 2076-2080
pJC 2081-2084, 
2092
pJC 2085-2091
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pK18 vector, insert is Bal31 digest of pJC2017 
from the 5' terminus of KpnI-N. The EcoRI site 
was regenerated at the 5' end with a linker.
Sequences have been determined (see Appendix B).
pK18 vector. Insert is Bal31 digest of pJC2017 
from the 3' terminus of KpnI-N. The Bam site at 
the 3' end was regenerated with a linker.
Sequences have been determined (see Appendix B).
pK18 vector. Insert is Bal31 digest of pJC2017 
from the 3' terminus of KpnI-N. The Baml ll site at 
the was regenerated with a linker. Sequences have 
been determined (see Appendix B).
APPENDIX B 
SEQUENCE CONFIRMATION FOR 
CLONED DNA FRAGMENTS
The numbering system is based on the Sal/Bam fragment from 
the BamHI-G fragment taken from GenEMBL of HSV-1 (17) 
(McGeogh et al., 1988). The first base of the Sail site is numbered 1. 
The KpnI-N fragment begins at number 1269 and ends at 5969 (Same 
as text figure 6). Truncated clones from the KpnI-N fragment of 
HSV-1 (KOS) Clones are listed in numerical order. (Uppercase = 
pUC vector sequence, Lowercase = UL28 gene sequence)
Plasmid pJC2017
5' AGTGAATTCGAGCTCGgtacctgccccacgccgccgggctg
3' TAGAGGATCCCCGGgtaccatgggatgtcttcatgtatatcttttt
5' deletions:
Clone Name Beginning/Ending (UL28 position)
1. pJC2076 (1982) AGTGAATTCGCggggcccgagacgtgggggg
2. pJC 2081 (2525) AGTGAATTCGCcgaatttcagaggttttactgttt
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3' deletions:
1. pJC 2082 (3020) agttcccccggcacgccCCTAGGAGATCTC
3. pJC 2083 (3371) ttcaaggagaacatcgcCCTAGGAGATCTC
4. pJC 2086 (4387) gttgcgcaggcacgagcCCTAGGAGATCTC
APPENDIX C
PRIMERS FOR DNA SEQUENCING
The primers are listed in order that they fall on the genomic 
map As mentioned in a previous appendix, the map used for num­
bering is the Sal/Bam fragment of BamHI-G from HSV-1 (17) (See 
Figure 6). Forward primers are listed in a normal typeface and 
reverse primers are in italics.
Location Name Sequence (5'-3')
1421 TPSEQ28 ggcgcacgacgtgtttcagg
1585 TPSEQ27 ccgcggcggtctcctgctgca
1611 TPSEQ26 cggcgggcggagcatttcgat
1772 TPSEQ25 ccgcaagagcggcgtcgtca
1785 TPSEQ24 cccgaacagtgcgacgagga
1966 TPSEQ23 cggcgacggtcttcgtcct
1986 TPSEQ22 cccgagacgtggggggacat
2135 TPSEQ21 ccgcagcatcttctcgagct
2172 TPSEQ19 gccgcggtcgccaacggcttt
2318 TPSEQ18 gtccacctggtgtcgcaggaga
2372 TPSEQ9 cctctttgatcactccacccaca
2571 TPSEQ17 gcgttattccggaaatgccgt
2609 TPSEQ12 gattatcgccaccacactctt
2751 TPSEQ15 gcggacagtcggagtcgtacgt
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2822 TPSEQ7
2962 TPSEQ13
3033 TPSEQ14
3133 TPSEQ8
3225 TPSEQ16
3295 TPSEQ11
3474 TPSEQ20
cgttttctcgatcctctactcg
agagcgcccatacgacgaac
cgcgacccaggcggcgaa
tcggttttttgttcttcttcggt
ggagaacaccgatgcaaactt
gctgctcgaactgcaccacc
gcggtcctcaaagatccccataaa
Universal Primers (New England Biolabs, Beverly, MA): 
(-24) Reverse Sequencing Primer: aacagctatgaccatg
(-40) Sequencing Primer: gttttcccagtcacgac
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